Vulvovaginal ulceration/inflammation in other diseases

N14_VULVOVAGINFINOTH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions None	313377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N77* Cause of death: ICD-10 — N77* 2 out of 7 registries used, show all original rules.	3338
4. Check minimum number of events None	3338
5. Include endpoints None	3338
6. Filter based on genotype QC (FinnGen only)	3043

Control definitions (FinnGen only)

Control exclude: N14_FEMALEGENINF

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	N14_VULVOVAGINFINOTH
CONTROL_EXCLUDE	N14_FEMALEGENINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N77
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N77
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Vulvovaginal ulceration/inflammation in other diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Vaginal lichen planus

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13884	13884	-
Only index persons	13459	13459	-
Unadjusted period prevalence (%)
Whole population	0.40	0.40	-
Only index persons	0.49	0.49	-
Median age at first event (years)
Whole population	-	30.72	-
Only index persons	-	30.83	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3043	3043	-
Unadjusted period prevalence (%)	1.08	1.08	-
Median age at first event (years)	40.04	40.04	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3178: Matched controls
31780

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N76.0

ICD-10 Finland

Acute vaginitis

5.6

307.7

805

1824

N77.1*A60.0

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection

104.4

307.7

524

J02AC01

ATC

fluconazole; systemic

4.9

307.7

2421

12508

N77.1

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere

66.3

307.7

725

141

N77.0*A60.0

ICD-10 Finland

Ulceration of vulva in herpesviral [herpes simplex] infection

74.1

307.7

259

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

76.4

307.7

1596

414

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

9.7

282.5

346

394

N77.8*L43.9

ICD-10 Finland

Vulvovaginal ulceration and inflammation caused by lichen ruber planus

360.4

236.6

236

J05AB01

ATC

aciclovir; systemic

3.2

200.2

1202

5128

J05AB11

ATC

valaciclovir; oral

3.5

192.8

860

3059

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

8.1

183.7

258

345

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

6.9

176.0

284

443

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

10.0

166.5

195

207

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

9.1

157.8

198

230

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

4.0

150.2

482

1359

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.8

141.7

957

4226

N76.3

ICD-10 Finland

Subacute and chronic vulvitis

15.9

139.0

120

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.4

122.0

1352

7466

ULA02

NOMESCO Finland

Kolposcopy

2.9

121.5

723

2958

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

5.7

111.8

217

404

L43.9

ICD-10 Finland

Lichen planus, unspecified

7.9

111.3

155

204

N77.0

ICD-10 Finland

Ulceration of vulva in infectious and parasitic diseases classified elsewhere

53.5

110.3

J02AC02

ATC

itraconazole; systemic

2.6

107.5

779

3501

D07AD01

ATC

clobetasol; topical

2.7

106.8

744

3279

L29.2

ICD-10 Finland

Pruritus vulvae

5.6

100.5

199

377

P01AB01

ATC

metronidazole; oral, rectal

2.2

98.1

1585

9975

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.1

90.8

1601

10317

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

88.5

1548

9915

N76.6

ICD-10 Finland

Ulceration of vulva

10.5

83.8

G01AA10

ATC

clindamycin; vaginal

2.2

77.4

816

4258

N76.2

ICD-10 Finland

Acute vulvitis

11.4

77.2

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

8.2

75.7

101

126

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

2.0

74.7

1760

12268

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.2

66.9

687

3521

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

3.7

62.7

204

571

L43.8

ICD-10 Finland

Other lichen planus

6.1

62.1

110

187

J01EA01

ATC

trimethoprim; systemic

1.9

60.6

1077

6701

R30.0

ICD-10 Finland

Dysuria

3.3

60.2

236

746

J01CA08

ATC

pivmecillinam; oral

1.9

59.9

1909

14244

D06BB03

ATC

aciclovir; topical

3.3

59.8

235

744

N77.8

ICD-10 Finland

Vulvovaginal ulceration and inflammation in other diseases classified elsewhere

203.8

58.2

J01MA02

ATC

ciprofloxacin; systemic

1.9

56.2

1087

6914

N30.9

ICD-10 Finland

Cystitis, unspecified

2.7

56.2

325

1278

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

55.9

856

5043

A02BC05

ATC

esomeprazole; systemic

1.8

55.3

1295

8728

N30.0

ICD-10 Finland

Acute cystitis

2.0

55.2

802

4637

E0000UV, ,

ATC

1.8

52.4

1547

11106

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

50.6

611

3296

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

49.6

1197

8070

N94.1

ICD-10 Finland

Dyspareunia

4.1

48.1

133

331

J01DB01

ATC

cefalexin; oral

2.1

47.5

2734

23617

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

46.1

825

5065

LEB00

NOMESCO Finland

Biopsy of vagina

4.4

45.5

116

271

R51.80

ICD-10 Finland

Headache

1.9

44.8

713

4211

N72

ICD-10 Finland

Inflammatory disease of cervix uteri

17.0

44.5

N76

ICD-10 Finland

Other inflammation of vagina and vulva

4.7

44.2

103

224

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

43.5

746

4506

A02BC02

ATC

pantoprazole; systemic

1.7

43.0

2062

16521

J01FA10

ATC

azithromycin; systemic

1.7

42.9

2137

17296

UKC02

NOMESCO Finland

Cystoscopy

2.5

42.5

294

1257

R52.9

ICD-10 Finland

Pain, unspecified

2.2

41.5

385

1867

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

41.2

696

4177

D07AC01

ATC

betamethasone; topical

1.7

40.7

1167

8141

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

3.8

40.6

128

350

R01AD09

ATC

mometasone; nasal

1.6

40.5

1705

13115

X15

ICPC

Vaginal symptom/complaint other

2.4

40.0

292

1278

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

39.3

471

2516

N70.0

ICD-10 Finland

Acute salpingitis and oophoritis

74.5

39.0

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.9

38.1

570

3281

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

4.7

38.1

194

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

37.7

800

5120

N30

ICD-10 Finland

Cystitis

2.0

37.5

435

2293

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.6

37.4

223

887

A02BC03

ATC

lansoprazole; oral

1.8

37.3

777

4946

N02AX02

ATC

tramadol; systemic, rectal

1.6

37.1

1139

8038

H02AB06

ATC

prednisolone; systemic

1.6

37.0

1416

10555

U01

ICPC

Dysuria/painful urination

2.1

36.6

379

1916

R53

ICD-10 Finland

Malaise and fatigue

1.7

36.4

938

6323

UJF32

NOMESCO Finland

Coloscopy

1.8

36.1

654

3990

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

35.8

2128

17572

N06AX11

ATC

mirtazapine; oral

1.6

35.5

1113

7876

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

35.5

1280

9374

N771, B977,

ICD-10 Finland

+∞

35.5

X90

ICPC

Genital herpes female

6.5

35.0

M79.6

ICD-10 Finland

Pain in limb

1.6

34.6

1486

11322

J01AA02

ATC

doxycycline; systemic

1.7

34.2

2357

20071

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

176.9

33.8

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

33.6

1008

7035

N90.8

ICD-10 Finland

Other specified noninflammatory disorders of vulva and perineum

4.3

33.4

207

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

33.3

1108

7928

G01AF05

ATC

econazole; vaginal

2.1

32.7

355

1823

XKD00

NOMESCO Finland

Uroflowmetry

3.0

32.6

148

509

U02

ICPC

Urinary frequency/urgency

1.8

32.3

581

3525

A10AE04

ATC

insulin glargine; parenteral

2.4

31.5

237

1049

R06.0

ICD-10 Finland

Dyspnoea

1.7

31.3

748

4911

A10BK03

ATC

empagliflozin; oral

2.4

31.2

235

1041

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

31.0

590

3635

N05BA04

ATC

oxazepam; oral

1.6

30.9

876

6004

SPAT1262

SPAT

Handing over of treatment supplies

1.9

30.6

410

2265

M01AH05

ATC

etoricoxib; oral

1.6

30.2

1955

16131

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

30.1

517

3090

M79.1

ICD-10 Finland

Myalgia

1.7

29.8

599

3744

D06BB10

ATC

imiquimod; topical

2.5

29.7

198

829

C05AA08

ATC

fluocortolone; rectal, topical

2.0

29.7

378

2051

G44.2

ICD-10 Finland

Tension-type headache

1.8

29.6

577

3574

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

29.6

322

1652

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

29.4

524

3162

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

29.4

707

4639

J01FF01

ATC

clindamycin; systemic

1.6

29.1

795

5385

M03BX02

ATC

tizanidine; oral

1.5

29.1

2022

16874

N71.9

ICD-10 Finland

Inflammatory disease of uterus, unspecified

6.1

28.9

J01MA12

ATC

levofloxacin; systemic

1.9

28.5

439

2533

R05

ICD-10 Finland

Cough

1.7

28.4

726

4832

D06

ICPC

Abdominal pain localized other

1.9

28.4

379

2089

X72

ICPC

Genital candidiasis female

3.4

28.3

101

300

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

28.3

1097

8056

R01AD58

ATC

fluticasone, combinations; nasal

1.6

28.1

1049

7639

R01AD12

ATC

fluticasone furoate; nasal

1.5

28.1

1258

9534

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.6

28.0

898

6316

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

27.9

241

1130

J01DA01

ATC

[U] cefalexin

1.5

27.4

1909

15837

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

27.3

433

2519

M01AE02

ATC

naproxen; oral, rectal

1.5

27.2

1920

15958

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

27.0

327

1743

R03AC02

ATC

salbutamol; inhalant

1.5

26.9

1856

15335

N02BE01

ATC

paracetamol; systemic, rectal

1.9

26.9

2812

25605

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

26.8

1756

14351

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

273.3

26.8

A07AA02

ATC

nystatin; oral

2.5

26.7

168

685

K30

ICD-10 Finland

Functional dyspepsia

1.8

26.7

428

2499

A10BK01

ATC

dapagliflozin; oral

2.4

26.6

182

772

R06AX27

ATC

desloratadine; oral

1.5

26.5

1168

8792

R21

ICPC

Throat symptom/complaint

1.5

26.2

1012

7398

N05CF01

ATC

zopiclone; oral

1.6

26.1

826

5775

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

2.0

25.8

310

1647

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

25.7

688

4616

N03AX16

ATC

[U] pregabalin

1.7

25.4

612

3998

A02BA02

ATC

ranitidine; systemic

1.8

25.3

445

2669

K59.0

ICD-10 Finland

Constipation

2.4

25.2

174

741

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

25.1

451

2720

L43

ICD-10 Finland

Lichen planus

4.3

25.1

150

N90.4

ICD-10 Finland

Leukoplakia of vulva

8.9

25.1

M25.5

ICD-10 Finland

Pain in joint

1.5

24.9

1136

8581

R01AD08

ATC

fluticasone; nasal

1.5

24.9

997

7328

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

24.8

243

1197

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

24.4

444

2686

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

24.1

797

5611

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

24.0

429

2582

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

24.0

443

2691

N76.4

ICD-10 Finland

Abscess of vulva

6.5

23.9

R06AE07

ATC

cetirizine; oral

1.5

23.6

1572

12757

T90

ICPC

Diabetes non-insulin dependent

1.7

23.5

467

2894

M54.2

ICD-10 Finland

Cervicalgia

1.9

23.5

294

1582

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

23.5

477

2975

N90.9

ICD-10 Finland

Noninflammatory disorder of vulva and perineum, unspecified

4.8

23.4

113

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.6

23.3

596

3946

D01

ICPC

Abdominal pain/cramps general

1.7

23.3

499

3157

R42

ICD-10 Finland

Dizziness and giddiness

1.6

23.2

641

4322

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

23.2

616

4115

R07.0

ICD-10 Finland

Pain in throat

1.9

23.1

334

1883

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.7

23.1

449

2766

U07

ICPC

Urine symptom/complaint other

2.0

23.0

261

1358

A02BC01

ATC

omeprazole; systemic

1.6

22.8

761

5357

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

22.8

1046

7877

N95.0

ICD-10 Finland

Postmenopausal bleeding

2.0

22.8

276

1468

AA1AD

NOMESCO Finland

CT of head and brain

1.6

22.8

602

4015

J01FA09

ATC

clarithromycin; systemic

1.5

22.7

1013

7583

R33

ICD-10 Finland

Retention of urine

2.9

22.7

106

371

A60.9

ICD-10 Finland

Anogenital herpesviral infection, unspecified

8.2

22.6

R50.9

ICD-10 Finland

Fever, unspecified

1.7

22.4

450

2796

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.7

22.3

485

3076

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

22.3

715

4985

N06AB04

ATC

citalopram; systemic

1.6

22.1

638

4342

N75.0

ICD-10 Finland

Cyst of Bartholin gland

7.3

22.0

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

22.0

274

1472

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

21.8

161

707

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

21.6

375

2234

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

21.6

542

3565

LFB20

NOMESCO Finland

Destruction of lesion of vulva or perineum

5.3

21.5

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

21.5

1239

9724

L30.4

ICD-10 Finland

Erythema intertrigo

4.2

21.4

134

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

21.3

341

1983

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.0

21.3

258

1372

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

21.3

248

1301

S29

ICPC

Skin symptom/complaint other

1.6

21.3

636

4359

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

21.3

289

1597

R39.1

ICD-10 Finland

Other difficulties with micturition

3.6

21.3

193

M01AB05

ATC

diclofenac; systemic, rectal

1.4

21.2

1943

16581

A10AB05

ATC

insulin aspart; parenteral

2.1

21.2

195

938

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.5

21.1

130

525

M54.5

ICD-10 Finland

Low back pain

1.4

21.1

1214

9518

G01AF04

ATC

miconazole; vaginal

2.1

21.0

195

941

L17

ICPC

Foot/toe symptom/complaint

1.5

20.9

934

6969

A10BA02

ATC

metformin; oral

1.6

20.9

573

3846

E000006, ,

ATC

2.0

20.9

229

1176

H02AB04

ATC

methylprednisolone; systemic

1.7

20.8

404

2483

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

20.6

371

2232

R12

ICD-10 Finland

Heartburn

1.9

20.5

296

1666

L01

ICPC

Neck symptom/complaint

1.6

20.5

620

4256

N06AX21

ATC

duloxetine; oral

1.7

20.4

408

2529

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

20.3

918

6858

L43.0

ICD-10 Finland

Hypertrophic lichen planus

7.2

20.3

Z2221

NOMESCO Finland

Medical doctor

1.5

20.3

860

6345

G04CA02

ATC

tamsulosin; oral

3.1

20.2

265

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

20.0

410

2555

U71

ICPC

Cystitis/urinary infection other

1.9

20.0

286

1605

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

20.0

237

1250

A01AB09

ATC

miconazole; local oral

2.0

20.0

240

1272

K08.80

ICD-10 Finland

Toothache NOS

1.7

19.9

369

2237

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

4.8

19.9

J01MA06

ATC

norfloxacin; oral

1.7

19.6

385

2372

P01

ICPC

Feeling anxious/nervous/tense

1.5

19.6

677

4782

R07.3

ICD-10 Finland

Other chest pain

1.8

19.6

291

1653

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

19.5

1277

10203

R03DC03

ATC

montelukast; oral

1.6

19.5

584

3996

A99

ICPC

Disease/condition unspecnature/site

1.8

19.5

323

1897

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

19.4

207

1052

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.5

19.4

128

534

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

19.4

1175

9260

N75.1

ICD-10 Finland

Abscess of Bartholin gland

6.3

19.3

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

19.2

725

5213

G04BD12

ATC

mirabegron; oral

1.9

19.2

252

1375

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

19.2

147

656

Z01.2

ICD-10 Finland

Dental examination

1.4

19.1

1671

14022

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

19.1

301

1740

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.7

18.9

101

380

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

18.9

659

4660

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

18.9

603

4183

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

18.9

512

3423

6146A

ICD-9 Finland

Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Pelvic peritoneal adhesions, female

+∞

18.8

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

18.7

554

3780

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

18.6

827

6143

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

18.5

341

2064

L02

ICPC

Back symptom/complaint

1.7

18.4

405

2569

A10BJ06

ATC

semaglutide; parenteral

2.3

18.2

144

651

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

18.1

651

4627

Z71.8

ICD-10 Finland

Other specified counselling

1.4

18.0

1212

9691

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

3.3

18.0

200

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

18.0

170

825

J01FA06

ATC

roxithromycin; oral

1.4

18.0

1138

9004

N06AB03

ATC

fluoxetine; oral

1.7

17.9

398

2531

N06AX16

ATC

venlafaxine; oral

1.6

17.9

529

3604

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

17.9

668

4786

OAB50, ,

SPAT

2.0

17.8

196

1007

N06AB10

ATC

escitalopram; oral

1.5

17.8

793

5883

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.1

17.7

172

844

N77.8*M35.2

ICD-10 Finland

Ulceration of vulva in Behçet's disease

+∞

17.7

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

17.6

166

805

R35

ICD-10 Finland

Polyuria

2.3

17.6

140

634

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

17.5

402

2576

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

17.5

444

2916

M54

ICD-10 Finland

Dorsalgia

1.6

17.5

454

2998

R00.2

ICD-10 Finland

Palpitations

1.7

17.5

307

1831

N05CF02

ATC

zolpidem; oral

1.6

17.5

535

3670

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

2.8

17.5

310

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

17.4

148

689

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

17.4

180

904

R11

ICD-10 Finland

Nausea and vomiting

1.8

17.4

303

1804

U05

ICPC

Urination problems other

2.4

17.4

121

518

R51

ICD-10 Finland

Headache

1.8

17.3

249

1400

D11

ICPC

Diarrhoea

1.6

17.2

474

3173

J01DA09

ATC

[U] cefadroxil

1.5

17.2

792

5905

XQ800

NOMESCO Finland

Prick test

1.7

17.2

307

1839

G04BD11

ATC

fesoterodine; oral

3.3

17.2

206

A04

ICPC

Weakness/tiredness general

1.5

17.2

551

3819

A02BC04

ATC

rabeprazole; oral

1.8

17.1

277

1613

J05AB09

ATC

famciclovir; oral

5.5

17.1

N03AX12

ATC

[U] gabapentin; oral

1.6

17.1

415

2697

E000001, ,

ATC

1.5

17.0

659

4749

X14

ICPC

Vaginal discharge

2.2

17.0

150

710

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

16.9

273

1589

G03DB01

ATC

dydrogesterone; oral

1.5

16.9

552

3840

H01.0

ICD-10 Finland

Blepharitis

1.8

16.9

277

1620

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.0

16.8

175

881

WX002

NOMESCO Finland

Sedation and analgesia

1.6

16.8

441

2919

N06AA09

ATC

amitriptyline; systemic

1.9

16.8

235

1310

N76.5

ICD-10 Finland

Ulceration of vagina

6.3

16.7

A10BH01

ATC

sitagliptin; oral

2.1

16.7

166

822

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.7

16.7

336

2081

L82

ICD-10 Finland

Seborrhoeic keratosis

1.6

16.6

471

3175

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

16.5

236

1325

GD1AA, ,

SPAT

1.5

16.4

590

4184

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

4.3

16.4

G01AF01

ATC

metronidazole; vaginal

1.7

16.4

316

1935

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

16.2

122

540

P06

ICPC

Sleep disturbance

1.6

16.2

455

3058

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

16.2

858

6554

C07AA05

ATC

propranolol; systemic

1.5

16.2

710

5238

N64.4

ICD-10 Finland

Mastodynia

2.0

16.1

180

931

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

16.0

310

1900

X16

ICPC

Vulval symptom/complaint

2.7

16.0

331

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

15.8

757

5673

D06BB04

ATC

podophyllotoxin; topical

1.8

15.8

225

1260

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

15.7

985

7739

J01

ICD-10 Finland

Acute sinusitis

1.8

15.7

247

1426

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

15.7

560

3965

A01AB04

ATC

amphotericin B; local oral

2.4

15.6

106

449

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

15.6

696

5149

H02AB07

ATC

prednisone; oral

1.6

15.4

341

2162

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.8

15.4

249

1449

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

15.3

452

3072

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

15.3

734

5501

SPAT1310

SPAT

Counselling related to known health issue

1.4

15.2

946

7418

L03

ICPC

Low back symptom/complaint

1.4

15.1

978

7713

N01

ICPC

Headache

1.5

15.0

511

3579

R13

ICD-10 Finland

Dysphagia

2.0

15.0

177

933

H29

ICPC

Ear symptom/complaint other

1.6

15.0

336

2139

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

14.9

146

719

R06AX22

ATC

ebastine; oral

1.5

14.8

598

4333

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

14.8

489

3404

R06AE09

ATC

levocetirizine; oral

1.5

14.8

518

3650

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

14.7

406

2714

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

14.7

146

724

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

14.6

631

4629

D06BX01

ATC

metronidazole; topical

1.6

14.6

371

2432

R52.2

ICD-10 Finland

Other chronic pain

2.2

14.6

118

539

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.8

14.6

222

1269

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

14.6

313

1969

6140A

ICD-9 Finland

Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Acute salpingitis and oophoritis[S-O-ITIS ACUTA]

+∞

14.6

61207

ICD-8 Finland

Acute salpingitis and oophoritis, suspecta

+∞

14.6

N03AE01

ATC

clonazepam; systemic

2.0

14.6

149

746

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

14.6

498

3489

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

14.6

282

1727

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

14.5

167

873

N94.2

ICD-10 Finland

Vaginismus

6.6

14.5

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

14.4

481

3351

J01CA04

ATC

amoxicillin; systemic

1.5

14.4

2689

24997

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

14.4

302

1888

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

14.3

226

1306

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

14.3

113

511

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

14.2

266

1613

T89

ICPC

Diabetes insulin dependent

2.2

14.2

124

584

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

14.2

296

1849

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

14.1

388

2590

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

14.1

347

2257

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

14.1

554

3990

J01MA01

ATC

ofloxacin; systemic

1.9

14.1

173

924

G47.3

ICD-10 Finland

Sleep apnoea

1.5

14.0

469

3268

N05AH04

ATC

quetiapine; oral

1.5

14.0

569

4122

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

14.0

265

1612

R03BA02

ATC

budesonide; inhalant

1.5

14.0

554

3995

D07AC13

ATC

mometasone; topical

1.4

14.0

820

6348

D09

ICPC

Nausea

1.8

13.9

208

1183

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.1

13.9

131

637

H92.0

ICD-10 Finland

Otalgia

1.7

13.9

251

1509

S02

ICPC

Pruritus

2.1

13.8

137

678

N77

ICD-10 Finland

Vulvovaginal ulceration and inflammation in diseases classified elsewhere

53.6

13.8

F43.0

ICD-10 Finland

Acute stress reaction

1.7

13.8

285

1775

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.4

13.8

393

LEB30

NOMESCO Finland

Destruction of lesion of vaginal mucosa

4.9

13.8

M54.8

ICD-10 Finland

Other dorsalgia

2.0

13.8

161

846

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

13.7

306

1943

Z3231

NOMESCO Finland

Registered nurse

1.4

13.7

677

5085

C07AB07

ATC

bisoprolol; oral

1.4

13.7

919

7268

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.6

13.7

312

1992

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

13.7

164

869

N39.3

ICD-10 Finland

Stress incontinence

1.7

13.6

248

1495

N89.8

ICD-10 Finland

Other specified noninflammatory disorders of vagina

3.6

13.6

119

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

13.6

260

1588

N05BA12

ATC

alprazolam; oral

1.7

13.5

272

1684

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

13.4

113

525

R74

ICPC

Upper respiratory infection acute

1.3

13.4

1355

11393

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

13.4

343

2253

A01

ICPC

Pain general/multiple sites

1.6

13.3

293

1855

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.8

13.2

189

1060

A97

ICPC

No disease

1.4

13.2

602

4453

SPAT1312

SPAT

General health counselling

1.4

13.2

1021

8246

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

13.2

867

6829

D07AB08

ATC

desonide; topical

1.6

13.2

337

2213

L13

ICPC

Hip symptom/complaint

1.5

13.1

500

3575

TKD00

NOMESCO Finland

Dilatation of urethra

4.6

13.1

M02AA07

ATC

piroxicam; topical

1.4

13.0

819

6400

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

13.0

280

1761

J01AA04

ATC

lymecycline; systemic

1.5

13.0

481

3421

K58

ICD-10 Finland

Irritable bowel syndrome

2.1

12.9

115

547

J01AA07

ATC

tetracycline; systemic

1.5

12.8

513

3701

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

12.8

217

G04BD08

ATC

solifenacin; oral

2.1

12.8

127

630

SPAT1263

SPAT

Sampling

1.3

12.8

1267

10601

H57.1

ICD-10 Finland

Ocular pain

1.9

12.8

151

797

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

12.7

145

755

O99.80

ICD-10 Finland

The fear of childbirth

1.6

12.7

284

1805

A06AC51

ATC

ispaghula, combinations; oral

2.0

12.6

130

653

U29

ICPC

Urinary symptom/complaint other

2.4

12.6

353

SPAT1260

SPAT

Consultation of another employee

1.5

12.6

476

3395

KCV04

NOMESCO Finland

Distension of bladder with fluid

4.4

12.6

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

12.6

247

1517

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

3.4

12.6

130

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.7

12.5

242

EKA10

NOMESCO Finland

iopsy of buccal mucosa

2.6

12.5

265

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

12.5

154

825

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

12.4

315

2063

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

12.4

2912

27699

M01AH01

ATC

celecoxib; oral

1.5

12.4

410

2849

A10AB04

ATC

insulin lispro; parenteral

2.2

12.3

440

Z3226

NOMESCO Finland

Physiotherapist

1.5

12.3

444

3141

UJF92

NOMESCO Finland

Capsular endoscopy

2.6

12.2

280

H04AA01

ATC

glucagon; nasal, parenteral

2.3

12.2

390

R51.81

ICD-10 Finland

Facial pain NOS

2.3

12.2

390

D01BA02

ATC

terbinafine; oral

1.4

12.2

535

3926

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

12.2

311

2040

B37.0

ICD-10 Finland

Candidal stomatitis

3.4

12.2

128

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.0

12.2

124

621

R10.0

ICD-10 Finland

Acute abdomen

2.2

12.2

102

474

A10AE05

ATC

insulin detemir; parenteral

2.0

12.2

126

635

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

12.1

1267

10655

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

4.5

12.1

S01

ICPC

Pain/tenderness of skin

2.0

12.1

134

692

G04BD07

ATC

tolterodine; oral

2.2

12.1

443

G03CA04

ATC

estriol; systemic, vaginal

2.0

12.1

124

623

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

12.1

441

3125

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

11.9

211

1260

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

11.9

375

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.2

11.9

145

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

11.9

335

2248

G50.1

ICD-10 Finland

Atypical facial pain

2.7

11.8

238

D02

ICPC

Abdominal pain epigastric

1.7

11.8

216

1303

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

3.4

11.8

121

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

11.8

274

1758

R4110, ,

SPAT

1.5

11.8

349

2368

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

11.7

646

4929

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

3.6

11.7

107

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

11.7

252

1587

M79.7

ICD-10 Finland

Fibromyalgia

1.9

11.7

141

750

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

11.6

1057

8703

J01DC02

ATC

cefuroxime; systemic

1.8

11.6

173

984

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

11.6

259

1646

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.7

11.6

199

1180

F29

ICPC

Eye symptom/complaint other

1.5

11.6

325

2179

B02AA02

ATC

tranexamic acid; systemic

1.4

11.5

567

4242

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

11.5

153

839

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

11.5

432

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

11.5

345

2345

N89.5

ICD-10 Finland

Stricture and atresia of vagina

11.1

11.5

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

11.5

283

1840

N06AB06

ATC

sertraline; oral

1.5

11.5

408

2873

ZXE00

NOMESCO Finland

One hour or less

1.3

11.5

1109

9207

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

11.5

358

2455

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

11.5

301

1987

62200

ICD-8 Finland

Infective diseases of uterus (except cervix), vagina and vulva, Endometritis acuta

+∞

11.5

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

11.4

376

M01AC06

ATC

meloxicam; systemic, rectal

1.3

11.4

909

7341

S71

ICPC

Herpes simplex

3.1

11.4

149

R01AD59

ATC

mometasone, combinations; nasal

1.6

11.4

273

1765

M02AA10

ATC

ketoprofen; topical

1.5

11.4

380

2644

JAH01

NOMESCO Finland

Laparoscopy

1.9

11.3

146

793

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.1

11.3

112

555

XQ802

NOMESCO Finland

Epicutan test

1.8

11.3

163

917

ULC02

NOMESCO Finland

Hysteroscopy

1.8

11.3

178

1029

L43.3

ICD-10 Finland

Subacute (active) lichen planus

10.6

11.2

P03

ICPC

Feeling depressed

1.5

11.2

443

3183

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

11.2

233

1453

N89.9

ICD-10 Finland

Noninflammatory disorder of vagina, unspecified

4.3

11.2

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.9

11.2

188

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

11.2

2312

21207

ZY010

NOMESCO Finland

Hospital outpatient

1.7

11.2

186

1092

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.4

11.2

305

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

11.1

266

1717

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

11.1

112

559

R05

ICPC

Cough

1.3

11.1

802

6379

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

11.1

718

5616

XLA10, ,

NOMESCO Finland

1.8

11.1

161

908

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

11.1

2172

19764

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

2.1

11.0

473

XKC03

NOMESCO Finland

Water cystometry

2.4

11.0

313

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

11.0

112

561

B37.08

ICD-10 Finland

Other candidal stomatitis

3.8

11.0

N03AX11

ATC

topiramate; oral

2.1

11.0

107

528

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

11.0

268

1740

R30.9

ICD-10 Finland

Painful micturition, unspecified

3.4

11.0

112

R06.4

ICD-10 Finland

Hyperventilation

2.7

11.0

213

H10

ICD-10 Finland

Conjunctivitis

1.6

11.0

298

1983

A07EA02

ATC

hydrocortisone; rectal

2.6

10.9

242

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

10.9

171

987

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

10.9

785

6239

R01AD11

ATC

triamcinolone; nasal

1.6

10.9

261

1686

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

10.9

240

1520

X23

ICPC

Fear sexually transm dis female

1.5

10.9

329

2241

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.3

10.9

378

Z2446

NOMESCO Finland

Social worker

1.7

10.9

179

1049

ZXD05

NOMESCO Finland

Urgent procedure

1.3

10.8

861

6945

L50.8

ICD-10 Finland

Other urticaria

2.3

10.8

335

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

10.8

442

3199

N02BF01

ATC

gabapentin; oral

1.6

10.7

282

1861

K60.1

ICD-10 Finland

Chronic anal fissure

2.3

10.7

361

C01CA24

ATC

epinephrine; parenteral

1.6

10.7

235

1486

L18

ICPC

Muscle pain

1.9

10.7

135

729

F01

ICPC

Eye pain

2.0

10.7

108

540

J20

ICD-10 Finland

Acute bronchitis

1.5

10.7

311

2101

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.7

10.7

216

K60.0

ICD-10 Finland

Acute anal fissure

2.9

10.6

177

H00.00

ICD-10 Finland

Hordeolum

1.8

10.6

167

965

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

10.6

152

854

R30.1

ICD-10 Finland

Vesical tenesmus

2.6

10.6

234

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

10.6

257

1665

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

10.6

237

1506

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.9

10.6

123

646

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.1

10.6

102

501

S18

ICPC

Laceration/cut

1.3

10.6

1153

9702

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

10.6

861

6964

L08

ICPC

Shoulder symptom/complaint

1.4

10.5

605

4641

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

10.5

319

2174

R60.0

ICD-10 Finland

Localized oedema

1.6

10.5

275

1814

N03AX09

ATC

lamotrigine; oral

1.7

10.5

185

1105

A10AC01

ATC

insulin (human); parenteral

1.7

10.5

174

1022

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

10.5

1470

12770

H01

ICPC

Ear pain/earache

1.4

10.5

434

3147

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

10.4

261

1703

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

10.4

254

1647

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

10.4

882

7167

A92

ICPC

Allergy/allergic reaction NOS

1.9

10.4

139

764

A10AB01

ATC

insulin (human); parenteral

2.1

10.4

464

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

10.4

243

1561

A06AD11

ATC

lactulose; oral

1.6

10.3

258

1683

G43

ICD-10 Finland

Migraine

1.5

10.3

283

1886

A10BJ05

ATC

dulaglutide; parenteral

2.8

10.3

180

G03HB01

ATC

cyproterone and estrogen; oral

1.4

10.3

480

3552

N70.9

ICD-10 Finland

Salpingitis and oophoritis, unspecified

32.6

10.3

Z2445

NOMESCO Finland

Psychologist

1.9

10.3

135

738

S06.0

ICD-10 Finland

Concussion

1.5

10.3

288

1928

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.5

10.3

102

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.4

10.3

443

3234

N63

ICD-10 Finland

Unspecified lump in breast

1.5

10.2

287

1922

1410

FHL

Laparoscopy

2.3

10.2

330

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

10.2

1289

11036

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

10.2

684

5371

SDA03

NOMESCO Finland

Periodontal treatment

1.3

10.2

1350

11631

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

10.2

258

1690

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

10.2

126

677

N30.2

ICD-10 Finland

Other chronic cystitis

3.4

10.1

103

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

10.1

233

1491

O04.6

ICD-10 Finland

Medical abortion, complete or unspecified, complicated by delayed or excessive haemorrhage

2.6

10.1

222

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.0

10.1

144

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

10.1

228

1453

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.6

10.1

231

1477

S21

ICPC

Skin texture symptom/complaint

1.4

10.1

413

2988

C03CA01

ATC

furosemide; systemic

1.4

10.0

396

2844

R4110

NOMESCO Finland

Physiotherapy

1.3

10.0

660

5170

LDA10

NOMESCO Finland

Curettage of cervix uteri

1.7

9.9

170

1007

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

9.9

1230

10497

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.4

9.9

425

3099

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

9.9

136

755

N64.5

ICD-10 Finland

Other signs and symptoms in breast

2.0

9.9

112

584

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.2

9.9

355

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

9.9

267

1775

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

9.8

165

972

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

9.8

520

3932

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.8

9.8

144

816

M35.2

ICD-10 Finland

Behçet disease

26.1

9.8

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.8

9.8

142

802

N06AX26

ATC

vortioxetine; oral

1.5

9.8

279

1876

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

9.8

181

1096

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

9.8

173

1035

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

9.8

251

1649

M01AH02

ATC

rofecoxib; oral

1.6

9.6

237

1541

R02

ICPC

Shortness of breath/dyspnoea

1.5

9.6

335

2347

EB1VA, ,

NOMESCO Finland

1.4

9.6

545

4165

H93.1

ICD-10 Finland

Tinnitus

1.7

9.6

177

1070

D01AC03

ATC

econazole; topical

1.9

9.6

116

618

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

9.6

488

3664

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

9.6

2390

22189

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

9.5

106

549

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

9.5

217

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

9.5

208

1314

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.5

9.5

223

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

9.5

780

6299

P01AB02

ATC

tinidazole; oral, rectal

2.2

9.5

341

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

9.5

1170

9962

N01BB02

ATC

lidocaine; parenteral

3.5

9.5

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

9.4

234

1524

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.7

9.4

153

893

K03.66

ICD-10 Finland

Tooth plaque

1.6

9.4

214

1365

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

9.4

236

1542

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

7.5

9.4

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.3

9.3

306

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

9.3

183

1127

B00.0

ICD-10 Finland

Eczema herpeticum

3.6

9.3

R03BA05

ATC

fluticasone; inhalant

1.4

9.2

536

4110

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

9.2

233

1524

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

2.6

9.2

203

A46

ICD-10 Finland

Erysipelas

1.6

9.2

235

1541

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

9.2

412

TLE00

NOMESCO Finland

Dilatation of vagina

13.7

9.2

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

3.9

9.1

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.1

9.1

374

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.6

9.0

205

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.4

9.0

389

2837

N05BA01

ATC

diazepam; systemic, rectal

1.5

9.0

298

2066

RS221, ,

NOMESCO Finland

2.8

9.0

154

TKC22

NOMESCO Finland

Catheterisation instruction

3.7

9.0

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.4

9.0

516

3950

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

9.0

107

568

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.8

8.9

138

795

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

8.9

316

2222

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

8.9

277

1898

Z00.0

ICD-10 Finland

General medical examination

1.4

8.9

514

3939

HA1RA, ,

SPAT

1.6

8.9

191

1203

UJH02

NOMESCO Finland

Anoscopy

2.0

8.9

514

X01

ICPC

Genital pain female

2.5

8.9

219

SPAT1283

SPAT

Restricted health certificate

1.3

8.9

750

6075

N83.1

ICD-10 Finland

Corpus luteum cyst

2.4

8.8

256

L71.0

ICD-10 Finland

Perioral dermatitis

2.0

8.8

480

N80.9

ICD-10 Finland

Endometriosis, unspecified

2.0

8.8

494

H00.1

ICD-10 Finland

Chalazion

1.8

8.8

118

651

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.5

8.8

208

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.0

8.8

433

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.0

8.8

440

N03AG01

ATC

valproic acid; systemic, rectal

1.7

8.8

154

920

L60.0

ICD-10 Finland

Ingrowing nail

1.7

8.8

141

822

SBA00

NOMESCO Finland

Microbiological examinations

2.2

8.8

340

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

8.8

477

3620

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

8.7

137

793

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

8.7

448

N80.0

ICD-10 Finland

Endometriosis of uterus

2.0

8.7

448

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.9

8.7

102

539

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

1.9

8.7

101

532

LFF00

NOMESCO Finland

Marsupialisation of Bartholin gland

50.1

8.7

ECA20

NOMESCO Finland

Biopsy of gingiva

3.1

8.7

114

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

8.6

139

810

X58

ICD-10 Finland

Exposure to other specified factors

1.4

8.6

402

2972

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

8.6

402

2972

B02

ICD-10 Finland

Zoster [herpes zoster]

1.8

8.6

120

670

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

8.6

837

6900

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

8.6

257

1745

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

8.6

161

979

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

8.6

969

8139

N81.6

ICD-10 Finland

Rectocele

1.6

8.6

193

1229

L50.9

ICD-10 Finland

Urticaria, unspecified

1.7

8.6

142

835

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

1.9

8.5

107

578

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.9

8.5

109

593

A10BH05

ATC

linagliptin; oral

2.2

8.5

305

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.4

8.5

242

R29

ICPC

Respiratory symptom/complaint other

1.6

8.5

196

1256

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

8.5

185

1169

UJD02

NOMESCO Finland

Gastroscopy

1.9

8.5

508

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

8.5

487

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

8.5

494

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.4

8.5

236

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.6

8.5

187

1186

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

8.5

175

1092

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

1.5

8.4

225

1491

D01AA02

ATC

natamycin; topical

2.4

8.4

243

C07AB02

ATC

metoprolol; systemic

1.4

8.4

330

2365

A07EC02

ATC

mesalazine; oral, rectal

1.7

8.4

138

809

L15

ICPC

Knee symptom/complaint

1.3

8.4

689

5552

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

8.4

727

5902

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.9

8.4

109

596

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

8.4

285

1988

N90.0

ICD-10 Finland

Mild vulvar dysplasia

4.5

8.4

N77.1*B80

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in pinworm infection

+∞

8.3

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.8

8.3

124

707

K64.1

ICD-10 Finland

Second degree haemorrhoids

2.2

8.3

334

G01AF08

ATC

tioconazole; vaginal

2.2

8.3

295

D82

ICPC

Teeth/gum disease

1.2

8.3

1285

11188

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.1

8.3

341

P76

ICPC

Depressive disorder

1.5

8.3

271

1875

M01AX17

ATC

nimesulide; oral

1.4

8.3

456

3466

G43.3

ICD-10 Finland

Complicated migraine

2.0

8.3

450

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

8.3

172

1075

H03AA01

ATC

levothyroxine sodium; systemic

1.3

8.3

714

5793

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

8.3

156

951

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.0

8.2

465

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.9

8.2

493

Z00.8

ICD-10 Finland

Other general examinations

1.5

8.2

226

1509

J02

ICD-10 Finland

Acute pharyngitis

1.6

8.2

177

1117

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.7

8.2

148

892

SPAT1324

SPAT

Screening procedure

0.7

8.2

498

6344

K07.60

ICD-10 Finland

Snapping jaw

1.6

8.2

211

1389

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.8

8.1

118

668

D03

ICPC

Heartburn

1.8

8.1

118

668

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.8

8.1

146

L04

ICPC

Chest symptom/complaint

1.6

8.1

179

1135

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

8.1

167

1041

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.8

8.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

8.1

260

C09CA06

ATC

candesartan; oral

1.3

8.1

586

4639

ZXA10

NOMESCO Finland

Bilateral

1.4

8.1

401

2995

SPAT1254

SPAT

Administration of medicine

1.4

8.1

351

2563

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.7

8.1

152

926

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

8.1

230

1547

X84

ICPC

Vaginitis/vulvitis NOS

2.5

8.1

199

K03.00

ICD-10 Finland

Approximal wear

1.5

8.0

241

1638

L20.0

ICD-10 Finland

Besnier prurigo

1.4

8.0

312

2232

A10AE06

ATC

insulin degludec; parenteral

2.0

8.0

455

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

8.0

240

1631

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

8.0

325

2344

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

8.0

103

562

R01AD01

ATC

beclometasone; nasal

1.4

8.0

432

3273

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

2.2

8.0

281

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

8.0

292

2066

A03

ICPC

Fever

1.3

8.0

611

4876

A10BG03

ATC

pioglitazone; oral

2.8

7.9

131

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

7.9

408

A10BB12

ATC

glimepiride; oral

2.2

7.9

301

R31

ICD-10 Finland

Unspecified haematuria

1.8

7.9

120

688

Z01.7

ICD-10 Finland

Laboratory examination

1.4

7.9

479

3692

K05.18

ICD-10 Finland

Chronic gingivitis

1.5

7.9

247

1693

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

7.9

243

1660

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

7.9

402

N17

ICPC

Vertigo/dizziness

1.4

7.9

329

2384

UJD10, ,

SPAT

2.1

7.9

348

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

7.9

246

1686

EMB10

NOMESCO Finland

Tonsillectomy

1.5

7.9

237

1612

L04AX01

ATC

azathioprine; systemic

1.8

7.9

111

623

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

7.9

131

772

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.1

7.9

342

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.9

7.8

508

N06AG02

ATC

moclobemide; oral

1.9

7.8

508

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

7.8

2301

21440

A03FA02

ATC

cisapride; oral, rectal

1.7

7.8

146

887

D07AA02

ATC

hydrocortisone; topical

1.4

7.8

432

3282

N02CC06

ATC

eletriptan; oral

1.7

7.8

154

949

N02BF02

ATC

pregabalin; oral

1.6

7.8

183

1177

Z30.5

ICD-10 Finland

Surveillance of (intrauterine) contraceptive device

1.4

7.8

346

2534

P02

ICPC

Acute stress reaction

1.5

7.8

253

1747

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.4

7.8

208

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

7.8

264

1839

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.6

7.8

176

1123

N75.8

ICD-10 Finland

Other diseases of Bartholin gland

10.8

7.8

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

7.8

177

1131

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

1.8

7.8

103

567

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.5

7.8

229

1551

J30.3

ICD-10 Finland

Other allergic rhinitis

1.7

7.8

127

745

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

7.7

318

2299

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

7.7

287

2036

RD210, ,

NOMESCO Finland

2.3

7.7

234

ZXC10

NOMESCO Finland

Use of laser

2.3

7.7

234

N87.0

ICD-10 Finland

Mild cervical dysplasia

1.8

7.7

116

664

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.8

7.7

139

C10AX09

ATC

ezetimibe; oral

1.5

7.7

262

1828

A07AA09

ATC

vancomycin; oral

2.9

7.7

117

M48.0

ICD-10 Finland

Spinal stenosis

1.6

7.7

187

1214

L28

ICPC

Limited function/disability (L)

1.4

7.7

368

2732

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.8

7.7

115

658

C10AA07

ATC

rosuvastatin; oral

1.3

7.6

668

5421

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.0

7.6

373

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

7.6

101

556

N06AX05

ATC

trazodone; oral

2.0

7.6

380

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.0

7.6

107

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.0

7.6

107

N02CD03

ATC

fremanezumab; systemic

2.4

7.6

217

G03CC04

ATC

estrone; systemic

2.3

7.6

242

G03DC02

ATC

norethisterone; oral

1.4

7.6

302

2170

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.2

7.6

287

J01XE01

ATC

nitrofurantoin; oral

2.3

7.6

255

G03DA02

ATC

medroxyprogesterone; systemic

1.5

7.6

228

1552

M03AX01

ATC

botulinum toxin; parenteral

2.1

7.5

341

D93

ICPC

Irritable bowel syndrome

2.2

7.5

256

N83.0

ICD-10 Finland

Follicular cyst of ovary

2.2

7.5

269

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.8

7.5

104

581

S04

ICPC

Lump/swelling localized

1.4

7.5

342

2518

A01AB10

ATC

natamycin; local oral

1.9

7.5

438

N05AH03

ATC

olanzapine; systemic

1.6

7.5

172

1102

B00

ICD-10 Finland

Herpesviral [herpes simplex] infections

4.2

7.5

R2110

NOMESCO Finland

Giving the first information

1.5

7.5

215

1450

UDM02

NOMESCO Finland

Sinoscopy

2.2

7.4

270

N64.9

ICD-10 Finland

Disorder of breast, unspecified

2.4

7.4

207

TLC02

NOMESCO Finland

Simple extraction of IUD

1.6

7.4

178

1152

D22

ICD-10 Finland

Melanocytic naevi

1.5

7.4

212

1427

SPAT1301

SPAT

No procedures

1.3

7.4

794

6608

L12

ICPC

Hand/finger symptom/complaint

1.3

7.4

524

4132

WX892

NOMESCO Finland

Monitored bed care

1.7

7.4

131

786

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

7.4

198

1315

C10AC01

ATC

colestyramine; oral

2.0

7.4

385

D10AX03

ATC

azelaic acid; topical

1.4

7.4

336

2474

J45

ICD-10 Finland

Asthma

1.4

7.3

315

2295

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

7.3

227

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.5

7.3

178

R09

ICPC

Sinus symptom/complaint

1.4

7.3

319

2330

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

7.3

108

615

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

2.0

7.3

379

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.2

7.3

272

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.7

7.3

129

773

O98.3

ICD-10 Finland

Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth and the puerperium

8.4

7.3

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.3

7.3

215

C10AA01

ATC

simvastatin; oral

1.3

7.3

526

4157

6150A

ICD-9 Finland

Inflammatory diseases of uterus, except cervix, Acute[ENDOMETRITIS, ENDOMYOMETRITIS ET PERIMETRITIS ACUTA]

+∞

7.3

Z70.8

ICD-10 Finland

Other sex counselling

3.1

7.3

F45.0

ICD-10 Finland

Somatization disorder

4.1

7.3

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.0

7.3

401

G04AC01, ,

ATC

1.9

7.3

436

N05AA02

ATC

levomepromazine; systemic

1.9

7.3

436

J04.0

ICD-10 Finland

Acute laryngitis

1.6

7.3

150

937

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

7.3

396

3003

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

7.3

682

5583

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.1

7.2

293

H60

ICD-10 Finland

Otitis externa

1.6

7.2

166

1064

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.9

7.2

508

N05BB01

ATC

hydroxyzine; systemic

1.6

7.2

176

1144

L50.3

ICD-10 Finland

Dermatographic urticaria

2.0

7.2

361

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.4

7.2

198

A10BJ02

ATC

liraglutide; parenteral

2.0

7.2

368

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.1

7.2

314

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.2

7.2

281

ZXA05

NOMESCO Finland

Left side

1.3

7.2

452

3504

BEF00, ,

SPAT

3.6

7.1

N97.9

ICD-10 Finland

Female infertility, unspecified

1.5

7.1

250

1755

S10

ICPC

Boil/carbuncle

1.6

7.1

149

934

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

7.1

729

6030

A10BH02

ATC

vildagliptin; oral

3.2

7.1

SPAT1240

SPAT

Therapeutic discussion

1.4

7.1

393

2986

JN1AE, ,

SPAT

1.7

7.1

137

841

N95.8

ICD-10 Finland

Other specified menopausal and perimenopausal disorders

2.2

7.1

256

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.7

7.1

125

749

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

7.1

116

681

K14.1

ICD-10 Finland

Geographic tongue

3.8

7.1

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.1

263

1867

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

7.1

234

1625

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

7.0

1663

15046

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

7.0

163

1048

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

4.4

7.0

N80.8

ICD-10 Finland

Other endometriosis

4.4

7.0

A07EA06

ATC

budesonide; oral, local oral

1.8

6.9

103

588

M77.4

ICD-10 Finland

Metatarsalgia

1.5

6.9

192

1284

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

6.9

185

1228

L09

ICPC

Arm symptom/complaint

1.6

6.9

154

980

S01XA18

ATC

ciclosporin; ophthalmic

3.0

6.9

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.5

6.9

181

1196

X57

ICD-10 Finland

Unspecified privation

2.2

6.9

259

LEE96

NOMESCO Finland

Other repair of vagina

13.8

6.9

A11

ICPC

Chest pain NOS

1.5

6.9

177

1165

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

6.9

173

1133

G03FA01

ATC

norethisterone and estrogen; systemic

1.4

6.9

339

2530

B07.9

ICD-10 Finland

Verruca simplex

1.7

6.8

112

658

R07.2

ICD-10 Finland

Precordial pain

2.5

6.8

172

Z72.2

ICD-10 Finland

Drug use

3.4

6.8

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

2.2

6.8

254

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.7

6.8

116

689

R32

ICD-10 Finland

Unspecified urinary incontinence

2.1

6.8

307

S06

ICPC

Rash localized

1.6

6.8

141

882

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

3.8

6.8

P29

ICPC

Psychological sympt/compl other

1.4

6.8

306

2248

R25.2

ICD-10 Finland

Cramp and spasm

2.1

6.8

314

R15

ICD-10 Finland

Faecal incontinence

2.0

6.8

355

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.0

6.8

328

SAA04

NOMESCO Finland

Special examination of mouth

1.6

6.8

149

946

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.6

6.7

136

845

X99

ICPC

Genital disease female other

3.1

6.7

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

6.7

169

1107

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

6.7

168

1099

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.1

6.7

302

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

6.7

141

885

K12.18

ICD-10 Finland

Other forms of stomatitis

3.2

6.7

K66.0

ICD-10 Finland

Peritoneal adhesions

3.9

6.7

D01AE15

ATC

terbinafine; topical

1.7

6.7

123

746

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

6.7

101

580

D05

ICPC

Perianal itching

3.4

6.7

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

6.7

148

941

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

6.7

290

2117

D05BB02

ATC

acitretin; oral

2.5

6.7

156

H65.2

ICD-10 Finland

Chronic serous otitis media

2.5

6.7

168

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

6.7

142

895

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

6.6

199

1354

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.1

6.6

270

A04AA01

ATC

ondansetron; systemic, rectal

1.5

6.6

202

1379

P25

ICPC

Phase of life problem adult

1.5

6.6

177

1175

L04AX03

ATC

methotrexate; systemic

1.4

6.6

248

1763

M01AX01

ATC

nabumetone; oral

1.9

6.6

443

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

6.6

101

582

L71.8

ICD-10 Finland

Other rosacea

2.1

6.6

264

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

6.6

130

803

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.1

6.6

284

H60.3

ICD-10 Finland

Other infective otitis externa

2.0

6.6

311

N06AB08

ATC

fluvoxamine; oral

2.0

6.6

311

A02BA04

ATC

nizatidine; systemic

1.7

6.6

125

765

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

2.9

6.6

100

C50.99

ICD-10 Finland

Breast, unspecified

1.9

6.6

423

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

6.5

1158

10156

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.3

6.5

201

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.6

6.5

141

892

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

6.5

292

2144

K03.80

ICD-10 Finland

Irradiated enamel

1.5

6.5

199

1360

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

6.5

123

752

R03BA01

ATC

beclometasone; inhalant

1.4

6.5

349

2639

D01AE16

ATC

amorolfine; topical

1.5

6.5

226

1585

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

6.5

293

2154

SFA00

NOMESCO Finland

Small restoration

1.3

6.5

397

3063

B02.9

ICD-10 Finland

Zoster without complication

1.6

6.5

144

917

S00.0

ICD-10 Finland

Superficial injury of scalp

2.2

6.5

240

A10AD01

ATC

insulin (human); parenteral

2.4

6.4

171

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

3.5

6.4

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.6

6.4

159

1038

A10BX07

ATC

[U] liraglutide

2.9

6.4

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.0

6.4

328

N81.1

ICD-10 Finland

Cystocele

1.5

6.4

165

1087

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.4

6.4

238

1690

SPAT1238

SPAT

Brief therapy

1.9

6.4

370

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.6

6.4

135

849

A29

ICPC

General symptom/complaint other

1.4

6.4

313

2333

K14.61

ICD-10 Finland

Glossodynia

3.0

6.4

P58

ICPC

Psychological, Therapeutic counselling/listening

1.8

6.4

500

LCG31

NOMESCO Finland

Laparoscopic resection or transcision of sacrouterine ligaments

4.1

6.3

G01AF02

ATC

clotrimazole; vaginal

1.7

6.3

105

620

N02CC04

ATC

rizatriptan; oral

1.5

6.3

218

1526

N87.1

ICD-10 Finland

Moderate cervical dysplasia

1.8

6.3

553

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.7

6.3

125

N94.9

ICD-10 Finland

Unspecified condition associated with female genital organs and menstrual cycle

3.6

6.3

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.7

6.3

100

583

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

6.3

192

1312

S80.0

ICD-10 Finland

Contusion of knee

1.4

6.3

240

1713

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

6.3

415

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.5

6.3

155

F51

ICD-10 Finland

Nonorganic sleep disorders

1.5

6.3

166

1101

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.2

6.3

786

6643

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.8

6.3

A10BD07

ATC

metformin and sitagliptin; systemic

2.0

6.3

297

61610

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female

+∞

6.3

R06.5

ICD-10 Finland

Mouth breathing

1.5

6.2

179

1208

S82

ICPC

Naevus/mole

1.3

6.2

434

3411

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

2.6

6.2

126

DM1QA, ,

SPAT

1.5

6.2

175

1176

KH1AD

NOMESCO Finland

CT of urinary organs

1.9

6.2

360

N06AX12

ATC

bupropion; oral

1.4

6.2

262

1904

D01AC02

ATC

miconazole; topical

1.6

6.2

128

801

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

6.2

138

880

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

6.2

432

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

6.2

240

1719

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.0

6.2

333

K14.6

ICD-10 Finland

Glossodynia

6.3

6.2

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

6.2

214

1501

Z51.6

ICD-10 Finland

Desensitization to allergens

2.2

6.1

226

G43.8

ICD-10 Finland

Other migraine

1.9

6.1

390

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

6.1

105

626

N02CD01

ATC

erenumab; parenteral

2.3

6.1

194

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

1.7

6.1

114

695

SPAT1336

SPAT

Request for examination

1.8

6.1

477

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

6.1

162

1075

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.9

6.1

391

ZXC50

NOMESCO Finland

Cryotherapy

2.3

6.1

201

N71.1

ICD-10 Finland

Chronic inflammatory disease of uterus

12.5

6.1

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.7

6.1

112

681

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

6.1

273

2007

N94.4

ICD-10 Finland

Primary dysmenorrhoea

1.7

6.1

108

651

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

6.0

211

1481

D16

ICPC

Rectal bleeding

2.0

6.0

301

160

Kela drug reimbursment

exenatide

2.4

6.0

158

L29.0

ICD-10 Finland

Pruritus ani

2.5

6.0

146

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.5

6.0

146

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026389) Candida sp identified in Specimen by Organism specific culture

224

468

5.07

101.33

1.7

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2463

19267

2.24

77.17

6.6

4.1

407.24

2442.27

e6/l

2.85

208

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1048

6478

1.92

60.04

2.7

2.1

—

(40768804) Tissue Pathology biopsy report

1664

11934

1.83

59.06

2.3

2.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

737

4123

2.03

55.83

2.3

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

154

386

4.14

55.17

1.3

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1105

7171

1.83

52.87

2.9

2.2

—

(3048689) Calprotectin [Mass/mass] in Stool

811

4781

1.93

52.35

2.5

90.17

96.93

ug/g

0.38

651

3767

(3018095) Leukocytes [#/volume] in Urine

1402

9863

1.75

50.30

4.9

3.4

162.09

85.00

e6/l

0.77

991

6311

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

839

5071

1.89

49.82

2.5

2.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1260

8652

1.76

48.80

1.4

1.79

1.65

u/ml

0.11

363

2552

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2488

20794

1.91

47.76

5.2

4.1

9.85

10.10

mm/h

0.52

2365

19715

(3015736) pH of Urine

1664

12409

1.72

47.38

4.2

3.1

6.24

6.26

0.20

993

7076

(3009261) Glucose [Presence] in Urine by Test strip

2006

15797

1.73

46.31

5.2

3.6

2.63

0.01

estimate

0.50

383

3322

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1288

9008

1.72

45.95

1.7

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

1976

15533

1.72

45.53

5.1

3.5

0.00

estimate

0.16

392

3346

(3035350) Ketones [Presence] in Urine by Test strip

1986

15685

1.71

44.45

5.2

3.5

10.16

3.73

estimate

0.55

403

3396

(3002582) Erythrocytes [#/volume] in Urine

1142

7796

1.73

43.98

4.1

2.9

83.68

80.87

e6/l

0.03

874

5708

(40768797) Stomach Pathology biopsy report

633

3623

1.93

43.64

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1470

10806

1.67

42.46

2.2

1.9

101.91

99.19

pmol/l

1.27

792

5723

(3007853) Bacteria identified in Skin by Aerobe culture

544

2995

1.98

41.86

2.0

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1706

13066

1.66

41.73

6.0

5.6

9.30

9.83

umol/l

2.56

1603

12373

(3026008) Bacteria identified in Urine by Culture

1226

8651

1.68

41.02

3.7

2.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1065

7274

1.70

40.08

1.6

1.4

2.08

2.10

g/l

0.17

689

4667

(3030467) Casts [#/volume] in Urine by Automated count

998

6720

1.71

39.47

3.9

2.8

0.29

0.32

e6/l

0.12

730

4715

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2144

17559

1.68

39.15

4.0

3.3

70.36

67.29

ug/l

0.47

2038

16719

(3013115) Eosinophils [#/volume] in Blood

1890

15008

1.64

38.79

7.8

6.3

0.18

e9/l

0.94

1684

13446

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1142

8013

1.66

38.40

3.0

2.4

54.47

57.57

u/l

1.80

1063

7446

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2365

19969

1.72

37.58

8.8

7.2

71.48

73.53

u/l

2.60

2249

19006

(3000850) Epithelial cells [#/volume] in Urine

817

5283

1.74

37.01

3.3

2.4

10.61

8.96

e6/l

0.34

744

4760

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1401

10418

1.62

36.91

6.1

5.3

1.22

mmol/l

0.37

1295

9713

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

8.14

36.72

1.2

1.1

—

(3006315) Basophils [#/volume] in Blood

1824

14469

1.61

36.60

7.7

6.2

0.04

e9/l

0.94

1597

12759

(3001604) Monocytes [#/volume] in Blood

1819

14450

1.61

36.02

7.7

6.1

0.53

e9/l

0.12

1595

12755

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1736

13643

1.60

35.93

2.8

2.5

77.02

75.15

nmol/l

2.15

1620

12825

(3022096) Basophils/Leukocytes in Blood

1684

13156

1.60

35.61

7.8

6.2

0.67

0.69

1.04

1571

12366

(3019069) Monocytes/Leukocytes in Blood

1683

13190

1.59

34.76

7.8

6.2

8.11

8.22

1.03

1578

12452

(3013650) Neutrophils [#/volume] in Blood by Automated count

1976

16094

1.60

34.52

10.3

8.9

3.94

e9/l

0.02

1734

14165

(3006504) Eosinophils/Leukocytes in Blood

1680

13175

1.58

34.50

7.7

6.2

2.68

2.76

0.71

1572

12409

(3014051) Protein [Presence] in Urine by Test strip

1219

8871

1.61

34.41

3.4

2.7

0.00

0.04

—

142

(3019198) Lymphocytes [#/volume] in Blood

1851

14866

1.59

34.15

7.7

6.1

2.00

1.97

e9/l

0.35

1657

13415

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3041

28159

2.85

33.83

17.7

11.8

17.55

19.19

mg/l

2.66

2562

22532

(3002030) Lymphocytes/Leukocytes in Blood

1721

13707

1.56

32.00

7.7

6.1

30.15

29.54

1.73

1629

13065

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1523

11829

1.55

31.51

6.8

5.9

1.22

mmol/l

0.12

1326

10270

(3018010) Neutrophils/Leukocytes in Blood

1693

13484

1.55

31.10

7.5

6.0

55.93

56.51

1.41

1614

12955

(3037522) Nuclear Ab [Titer] in Serum

726

4747

1.69

30.75

1.5

1.4

508.69

584.17

titre

0.54

145

1006

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2744

24607

1.84

30.33

6.0

4.9

14.36

14.39

pmol/l

0.33

2587

23180

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1107

8060

1.57

30.15

3.7

2.8

18.26

43.17

ng/l

1.31

515

3897

(3000494) Fungus identified in Specimen by Culture

535

3249

1.78

29.42

1.7

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1520

11929

1.53

29.14

5.0

3.3

0.04

0.08

estimate

0.44

323

2778

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2873

26237

1.99

28.75

14.3

10.7

91.44

90.60

ml/min/173m2

1.43

2609

23749

(3021960) Folate [Moles/volume] in Serum or Plasma

943

6685

1.58

28.48

1.8

1.6

20.88

20.91

nmol/l

0.02

836

5886

(3041096) Erythrocytes [Presence] in Urine by Automated

1192

8973

1.53

27.20

4.3

2.9

0.95

0.13

estimate

0.53

330

2744

(3024561) Albumin [Mass/volume] in Serum or Plasma

1380

10731

1.51

26.89

4.9

4.4

37.14

36.88

g/l

1.17

1301

10123

(46235355) HIV 1 and 2 tests - Meaningful Use set

1292

9916

1.51

26.78

2.5

2.1

—

(40768443) Skin Pathology biopsy report

244

1171

2.17

26.67

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

623

4052

1.67

26.44

3.3

2.5

0.90

1.28

e6/l

1.54

327

2001

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2958

27423

2.14

26.40

7.3

5.8

1.71

1.76

mu/l

2.10

2830

26206

(3019550) Sodium [Moles/volume] in Serum or Plasma

2937

27159

2.07

26.37

16.5

12.1

139.53

139.59

mmol/l

0.84

2889

26575

(3026782) Osmolality of Urine

673

4471

1.64

26.27

3.7

2.6

488.89

513.70

mosm/kgh2o

2.18

595

3900

(3023103) Potassium [Moles/volume] in Serum or Plasma

2939

27197

2.07

26.13

16.8

12.2

3.90

mmol/l

0.02

2883

26538

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

572

3674

1.68

25.36

3.5

2.6

4.61

4.89

e6/l

0.19

277

1621

(3009508) Creatinine [Moles/volume] in Urine

1032

7641

1.52

24.92

4.6

3.2

7.16

7.32

mmol/l

0.44

884

6654

(3013826) Glucose [Moles/volume] in Serum or Plasma

1798

14884

1.48

24.90

4.9

4.1

6.54

6.27

mmol/l

4.49

1659

13538

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

905

6522

1.54

24.74

2.0

1.8

0.67

0.92

mg/l

4.61

662

4942

(3025130) Human papilloma virus identified in Specimen

205

948

2.24

24.53

1.8

1.9

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2715

24634

1.70

24.11

6.5

4.8

38.44

37.18

mmol/mol

8.99

2595

23484

(3022145) Colonoscopy Study observation

465

2880

1.72

23.46

1.4

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

928

6825

1.51

22.70

2.3

2.0

113.08

137.57

u/l

2.29

872

6519

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

831

5986

1.53

22.37

1.4

1.3

6.92

9.16

u/ml

0.49

308

2536

(3045414) Leukocytes [Presence] in Urine

434

2672

1.72

22.30

2.3

2.0

0.00

0.03

estimate

2.11

615

(3044640) Blood type and Crossmatch panel - Blood

1192

9243

1.46

22.27

2.5

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

369

2186

1.78

21.68

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

886

6512

1.50

21.52

1.4

1.3

28.11

25.11

iu/ml

0.30

264

1939

(3036481) Cortisol [Moles/volume] in Serum or Plasma

468

2970

1.68

21.44

2.2

377.55

382.05

nmol/l

0.21

438

2748

(3017143) Hepatitis C virus Ab [Presence] in Serum

675

4683

1.56

21.43

1.8

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2556

23043

1.56

21.07

4.3

3.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

334

1941

1.81

20.91

1.7

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

284

1586

1.87

20.20

2.0

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

1087

8400

1.45

20.16

5.4

3.6

0.00

estimate

0.06

384

3234

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

185

891

2.14

20.00

1.6

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

437

2771

1.67

20.00

4.4

3.9

33.55

33.13

0.34

326

2023

(3042936) Bacteria identified in Isolate by Culture

486

3174

1.63

19.79

2.2

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

248

1334

1.93

19.77

1.8

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1147

8983

1.43

19.65

2.1

1.8

—

(3005322) IgE [Units/volume] in Serum or Plasma

402

2506

1.69

19.60

1.4

1.3

174.38

183.56

u/ml

0.08

375

2339

(3022948) Iron [Moles/volume] in Serum or Plasma

606

4179

1.56

19.56

2.7

2.3

14.72

14.09

umol/l

1.16

578

3894

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2296

20349

1.46

19.55

3.7

2.9

34.01

32.96

u/l

0.32

2198

19473

(3004789) Transferrin [Mass/volume] in Serum or Plasma

556

3773

1.57

19.23

2.6

2.3

2.47

g/l

0.02

514

3482

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3069

29258

2.43

19.23

19.2

13.9

66.65

66.49

umol/l

0.15

3043

28927

(3023368) Bacteria identified in Blood by Culture

737

5322

1.50

19.15

4.8

3.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.26

18.90

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

854

6368

1.47

18.85

5.3

4.1

6.83

8.71

mg/mmol

0.78

534

3791

(3015377) Calcium [Moles/volume] in Serum or Plasma

1138

8971

1.42

18.51

2.9

3.2

2.35

mmol/l

0.87

1039

8349

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3068

29284

2.38

18.46

13.3

10.1

23.50

23.45

u/l

0.06

3013

28621

(3033658) Prothrombin time (PT) actual/Normal

847

6334

1.46

18.33

4.3

3.4

97.89

97.08

0.50

832

6169

(3012516) Albumin [Mass/volume] in Urine

842

6295

1.46

18.23

4.4

3.4

41.22

47.98

mg/l

0.41

549

3764

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

503

3389

1.58

17.84

2.7

2.4

23.96

23.03

0.76

471

3144

(3028026) IgM [Mass/volume] in Serum or Plasma

285

1660

1.79

17.63

2.1

1.9

1.31

1.36

g/l

0.35

261

1543

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1190

9517

1.40

17.57

3.5

3.0

27.27

28.44

u/l

0.68

1111

9069

(3028679) Herpes simplex virus Ab [Presence] in Serum

245

3.07

17.50

1.2

—

(3022621) pH of Urine by Test strip

376

2386

1.65

17.02

2.9

2.4

6.19

6.17

0.13

223

1503

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

895

6845

1.43

16.92

2.5

2.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

808

6069

1.44

16.85

2.4

2.2

288.40

299.28

umol/l

3.26

712

5529

(3019225) pH of Specimen

338

2094

1.69

16.77

3.5

3.4

7.35

0.12

227

1491

(3032080) INR in Blood by Coagulation assay

1167

9370

1.39

16.56

10.8

8.9

1.08

1.11

inr

1.80

977

7740

(3019309) Folate [Moles/volume] in Red Blood Cells

498

3401

1.55

16.55

1.8

1.7

1182.07

1197.47

nmol/l

0.14

393

2627

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

155

753

2.11

16.41

1.5

1.3

—

(3025941) Bacteria identified in Stool by Culture

300

1811

1.72

16.36

1.3

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

342

2139

1.67

16.36

3.2

2.9

10.21

10.42

g/l

0.55

315

1991

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

352

2228

1.65

16.06

2.2

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

947

7391

1.40

15.72

2.6

2.2

2.57

2.64

mg/l

0.51

800

6453

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

694

5123

1.45

15.71

1.7

1.6

27197798.65

38435956.76

pmol/l

0.27

603

4436

(3018418) pH of Serum or Plasma

920

7146

1.40

15.70

4.5

3.6

7.40

0.62

657

5031

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

442

2977

1.56

15.56

3.5

2.4

5.07

6.19

umol/l

1.27

361

2520

(36660697) Celiac disease serology panel - Serum

435

2936

1.56

15.15

1.2

—

(3019150) Specific gravity of Urine by Refractometry

886

6888

1.40

14.90

5.0

3.6

2.69

1.47

kg/l

0.32

602

4470

(3012095) Magnesium [Moles/volume] in Serum or Plasma

521

3670

1.50

14.87

4.0

3.2

0.82

mmol/l

0.24

489

3465

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

472

3265

1.52

14.67

3.0

2.2

7577.89

6879.45

u/l

0.15

197

1367

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

208

1165

1.84

14.62

4.1

3.1

5.13

5.16

kpa

0.25

196

1126

(3009343) pH of Capillary blood

204

1136

1.85

14.61

3.9

3.1

7.41

7.42

0.40

165

948

(40761511) CBC panel - Blood by Automated count

3064

29442

2.13

14.55

15.1

10.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

244

1439

1.75

14.43

1.3

0.21

1.29

u/ml

2.31

109

(3045424) Erythrocytes [Presence] in Urine

228

1319

1.78

14.41

2.4

2.0

0.02

0.01

estimate

0.02

499

(3019832) Treponema pallidum Ab [Presence] in Serum

911

7152

1.38

14.34

2.0

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

224

1291

1.79

14.34

1.6

1.7

6.33

10.73

u/ml

2.18

368

(3020961) Endomysium IgA Ab [Titer] in Serum

297

1859

1.66

14.11

1.2

1.1

202.22

146.85

titre

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

726

5500

1.41

14.06

1.8

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1622

13946

1.33

13.93

3.0

2.6

—

estimate

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

661

4936

1.43

13.85

2.8

573.92

699.58

ng/l

0.83

529

4088

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

117

547

2.18

13.70

1.4

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

262

1604

1.69

13.54

1.5

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.13

13.47

1.2

1.3

94.89

97.15

0.19

(3029634) Reagin Ab [Titer] in Serum by VDRL

105

485

2.20

12.69

1.5

—

3.33

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

177

986

1.84

12.68

3.8

3.1

1.27

1.68

mmol/l

0.71

123

716

(3022313) Gas panel - Capillary blood

145

762

1.95

12.42

4.0

3.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

201

1174

1.76

12.30

1.4

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

370

2521

1.53

12.24

2.8

2.3

40.46

36.28

u/l

0.15

315

2101

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

475

3408

1.46

12.20

2.0

1.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

339

2269

1.55

12.16

2.5

2.4

19.21

19.44

au/ml

0.02

289

(3049717) Cytology report of Urine Cyto stain

410

2.28

12.13

2.2

2.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

143

756

1.93

12.04

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

324

2152

1.56

12.02

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

143

757

1.93

11.99

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

467

3372

1.45

11.57

1.3

136.44

156.53

u/ml

0.43

185

1364

(3014765) Yersinia sp identified in Stool by Organism specific culture

150

818

1.88

11.51

1.2

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

279

1815

1.59

11.31

1.5

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2868

27267

1.53

11.29

5.5

4.6

2.76

2.83

mmol/l

5.63

2730

26002

(42529406) Shigella sp [Presence] in Stool by Culture

150

825

1.86

11.21

1.2

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

313

2097

1.55

11.16

1.4

1.3

37.77

41.86

au/ml

—

115

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2839

26955

1.50

11.02

4.9

4.1

1.55

1.56

mmol/l

0.72

2697

25696

(3012544) pH of Venous blood

280

1837

1.57

10.95

4.1

3.5

7.38

0.70

170

1041

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

148

819

1.85

10.86

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2848

27072

1.50

10.84

5.0

4.2

4.72

4.80

mmol/l

4.73

2735

25903

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1027

8488

1.31

10.83

2.0

1.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

175

1020

1.76

10.81

1.8

2.2

0.22

0.23

g/l

0.68

169

967

(3030981) Hyaline casts [#/volume] in Urine by Automated count

270

1766

1.58

10.70

3.2

2.2

0.41

0.39

e6/l

0.07

254

1664

(3000570) Elastase.pancreatic [Mass/mass] in Stool

129

687

1.91

10.66

1.5

1.3

332.97

306.52

ug/g

0.73

340

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

168

972

1.77

10.65

1.2

4.71

4.32

0.25

150

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

616

4732

1.37

10.63

2.4

2.42

2.43

mmol/l

0.40

546

4252

(3048929) Epstein Barr virus Ab [Presence] in Serum

225

1411

1.64

10.61

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

179

1057

1.73

10.57

1.7

2.1

1.15

1.18

g/l

0.48

173

1005

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2739

25866

1.43

10.56

5.0

4.1

5.76

5.61

mmol/l

6.86

2571

24370

(3016879) Cocaine [Presence] in Urine

286

1902

1.55

10.54

3.8

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

249

1604

1.60

10.52

4.0

1.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

361

2531

1.48

10.36

3.3

3.6

4.53

4.52

pmol/l

0.02

317

2298

(3021447) Carbon dioxide [Partial pressure] in Venous blood

277

1837

1.56

10.33

4.3

3.5

5.87

5.78

kpa

0.85

267

1787

(3016650) Hepatitis A virus Ab [Presence] in Serum

100

494

2.06

10.24

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2689

25360

1.39

10.02

4.2

3.6

1.19

1.18

mmol/l

0.50

2531

24045

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

212

2.62

9.98

1.6

1.8

—

(40758558) Short blood count panel - Blood

993

8248

1.30

9.89

7.1

5.8

—

(3017732) Neutrophils [#/volume] in Blood

493

3691

1.40

9.89

3.0

2.8

4.04

4.29

e9/l

0.99

411

3329

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

515

3904

1.38

9.56

3.5

3.1

73.11

323.00

ng/l

3.48

254

2268

(3003458) Phosphate [Moles/volume] in Serum or Plasma

379

2725

1.44

9.53

6.9

5.1

1.05

mmol/l

0.15

356

2518

(3019420) Tryptase [Mass/volume] in Serum or Plasma

213

2.56

9.38

2.3

1.5

12.48

7.28

ug/l

0.36

187

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1295

11180

1.27

9.33

2.0

1.8

1.31

mmol/l

0.14

1112

9799

(3018677) aPTT in Platelet poor plasma by Coagulation assay

431

3191

1.41

9.19

2.2

2.0

29.00

28.87

0.25

414

3095

(3021879) Hepatitis B virus core Ab [Presence] in Serum

425

3143

1.41

9.12

1.5

—

(3011412) CD3 cells [#/volume] in Blood

272

2.34

9.03

2.5

2.4

1352.74

1272.80

e6/l

0.26

231

(3024354) Oxygen [Partial pressure] in Venous blood

233

1534

1.56

8.98

3.9

3.0

4.38

4.60

kpa

1.10

224

1488

(3002032) Base excess in Venous blood by calculation

263

1780

1.52

8.94

4.4

3.5

1.37

1.70

mmol/l

0.78

236

1549

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

506

1.97

8.92

6.5

5.2

317.00

428.04

iu/ml

0.23

(4062490) Immunoglobulin typing, IgG

312

2.24

8.89

1.5

1.4

—

(3028300) Cannabinoids [Presence] in Urine

299

2081

1.48

8.88

3.8

1.9

—

(3027008) Opiates [Presence] in Urine

297

2071

1.48

8.74

3.8

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

147

868

1.73

8.73

5.9

2.4

—

(3000764) Benzodiazepines [Presence] in Urine

296

2064

1.48

8.71

3.8

1.9

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

209

2.51

8.71

2.6

2.4

185.00

205.47

e6/l

0.47

168

(3007566) Smooth muscle Ab [Titer] in Serum

134

775

1.76

8.56

1.4

1.2

118.75

170.68

titre

0.29

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

338

2427

1.44

8.54

1.8

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

319

2274

1.45

8.38

4.2

4.5

218.79

237.67

u/l

1.58

306

2156

(3052851) Hemolysis interference index of Serum or Plasma

115

640

1.83

8.36

2.9

2.6

4.34

1.88

index

0.59

319

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

175

1097

1.63

8.30

2.4

2.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

361

2.10

8.29

2.8

71.45

86.23

ug/min

0.14

233

(3023323) Follitropin [Units/volume] in Serum or Plasma

437

3303

1.37

8.20

1.4

1.3

23.74

23.63

iu/l

0.02

377

2853

(3027944) Amphetamines [Presence] in Urine

292

2056

1.46

8.18

3.2

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

892

7459

1.27

8.11

5.1

4.2

—

(3007461) Platelets [#/volume] in Blood

3149

30961

2.87

8.06

26.7

18.6

266.15

268.34

e9/l

1.28

3127

30488

(3035941) MCH [Entitic mass]

3149

30965

2.86

7.98

26.5

18.5

30.09

30.01

1.76

3140

30760

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

498

1.91

7.98

1.2

1.1

—

(3000991) Gas panel - Venous blood

241

1641

1.51

7.98

7.8

7.7

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3149

30966

2.85

7.96

26.5

18.5

90.43

90.25

1.57

3140

30761

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3149

30967

2.85

7.94

26.9

18.8

39.81

40.15

0.87

3140

30749

(1002224) Polysomnography panel

221

1479

1.53

7.93

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

480

3701

1.35

7.92

1.7

1.6

1.38

1.33

1.51

426

3333

(3026361) Erythrocytes [#/volume] in Blood

3149

30969

2.84

7.90

26.6

18.6

4.43

4.44

e12/l

2.02

3123

30436

(3010813) Leukocytes [#/volume] in Blood

3149

30972

2.83

7.85

26.7

18.6

6.70

6.69

e9/l

0.01

3121

30422

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

245

2.31

7.83

1.5

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

2.69

7.73

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

3149

30978

2.81

7.73

26.8

18.7

132.46

132.66

g/l

0.49

3140

30770

(3028192) IgG subclass 2 [Mass/volume] in Serum

319

2.12

7.65

1.5

1.4

3.08

2.99

g/l

0.18

235

(3024139) IgG subclass 3 [Mass/volume] in Serum

319

2.12

7.65

1.5

1.4

0.40

g/l

0.03

234

(3027135) IgG subclass 1 [Mass/volume] in Serum

320

2.12

7.59

1.5

1.4

6.26

6.54

g/l

0.33

235

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

521

1.87

7.59

1.2

1.1

1.37

3.00

1.05

104

(4024509) Urine culture

195

1283

1.55

7.57

2.0

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

175

1124

1.59

7.54

4.2

3.9

24.14

24.17

mmol/l

0.04

175

1108

(3024891) Influenza virus A+B Ag [Presence] in Specimen

142

870

1.66

7.40

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

483

1.89

7.37

1.6

0.68

0.60

g/l

0.37

380

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

8.37

7.31

1.1

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

197

2.41

7.26

2.7

2.3

560.22

498.01

e6/l

0.45

150

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

302

2191

1.42

7.21

2.4

3.1

40.96

50.41

u/ml

0.21

291

2120

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

230

2.28

7.13

2.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

217

1481

1.50

7.12

1.9

2.1

7.02

7.46

iu/ml

0.07

378

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

232

2.26

6.99

1.2

—

(4146454) Self-monitoring of blood glucose

160

2.52

6.84

2.4

2.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

280

2.13

6.83

1.8

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

235

2.23

6.79

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

282

2.11

6.71

1.8

1.4

—

(3002256) Pathology report gross observation

470

3706

1.31

6.60

1.3

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

215

1490

1.48

6.56

6.6

2.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

295

2169

1.40

6.52

1.6

1.7

295.38

306.62

mu/l

0.21

268

1918

(3025468) Yersinia sp identified in Specimen by Organism specific culture

279

2.10

6.50

1.8

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

300

2.05

6.46

1.8

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

246

1759

1.43

6.38

4.1

3.3

71.84

72.60

ng/l

0.07

217

1551

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

152

988

1.57

6.27

1.1

2.06

6.25

eliau/ml

1.90

153

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

409

1.88

6.23

4.4

2.7

10000.83

635.83

u/ml

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

199

2.28

6.21

1.4

1.5

1.42

1.44

nmol/l

0.04

183

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

571

1.74

6.20

1.1

1.60

3.16

eliau/ml

1.59

312

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

133

841

1.61

6.17

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

267

1949

1.40

6.17

1.4

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

220

1551

1.45

6.16

2.6

69.73

71.77

e9/l

0.38

157

1109

(3047007) Chlamydophila sp Ab [Presence] in Serum

565

1.74

6.15

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

226

2.19

6.13

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

139

2.53

6.10

1.1

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

300

2.02

6.09

1.8

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

307

2.01

6.09

1.8

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

267

2.08

6.05

1.5

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

311

2337

1.37

6.03

1.9

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

175

1187

1.50

5.96

1.7

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

139

899

1.57

5.88

1.4

20.04

22.82

u/l

0.49

114

764

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

286

2132

1.38

5.83

2.7

2.2

0.23

0.22

g/l

1.37

271

2010

(3027945) Reticulocytes/Erythrocytes in Blood

287

2147

1.37

5.73

3.2

2.7

1.74

1.76

0.16

259

1916

(3009214) Lutropin [Units/volume] in Serum or Plasma

188

1305

1.47

5.72

1.3

10.74

11.28

u/l

0.16

148

1073

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.18

5.69

1.8

1.6

3.01

1.04

mg/l

0.56

(3004119) Hemoglobin [Mass/volume] in Venous blood

166

1125

1.50

5.69

3.3

2.8

129.77

129.91

g/l

0.03

159

1096

(3021589) Normoblasts [#/volume] in Blood

1426

12877

1.19

5.67

12.8

9.5

0.00

e9/l

0.09

1141

10612

(1616796) Gas panel - Central venous blood

431

1.81

5.61

4.1

2.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

255

2.06

5.59

1.8

1.9

13.68

23.76

mg/l

2.21

(3035320) C reactive protein [Mass/volume] in Body fluid

217

2.14

5.48

4.4

2.3

25.11

25.25

mg/l

0.01

152

(3020491) Glucose [Moles/volume] in Blood

217

2.14

5.48

2.2

1.5

7.59

5.76

mmol/l

2.05

169

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

160

1090

1.49

5.36

1.3

50.31

36.54

u/ml

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

113

713

1.61

5.34

1.2

1.1

13.98

14.32

au/ml

0.03

192

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

387

1.83

5.33

1.2

1.3

116.00

483.87

titre

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

154

1043

1.50

5.31

1.2

1.1

2.57

2.56

u/ml

0.01

527

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

388

1.82

5.29

1.2

1.3

—

316.67

—

(3010375) cycloSPORINE [Mass/volume] in Blood

2.84

5.24

26.8

29.3

120.94

106.11

ug/l

0.52

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

183

1288

1.45

5.21

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

210

1516

1.41

5.20

2.2

2.6

66.39

67.14

g/l

0.86

194

1421

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

129

848

1.54

5.13

2.3

2.0

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.86

5.11

1.8

1.6

3.24

1.32

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.86

5.11

1.8

1.6

0.88

2.03

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.86

5.11

1.8

1.6

4.37

3.37

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.86

5.11

1.8

1.6

3.36

1.91

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.86

5.11

1.8

1.6

4.50

3.68

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.86

5.11

1.8

1.6

0.52

0.92

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.86

5.11

1.8

1.6

7.16

1.84

mg/l

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

152

2.32

5.09

1.1

9.06

9.58

u/ml

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

317

2453

1.32

5.08

5.2

4.9

—

(3004809) Band form neutrophils/Leukocytes in Blood

300

1.92

5.07

3.1

1.56

1.45

0.10

275

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.18

5.03

3.1

5.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

127

836

1.54

5.02

1.8

2.1

1.30

1.40

g/l

0.62

110

728

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

3.29

5.02

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

168

1172

1.46

5.02

2.2

2.1

39.97

39.09

u/l

0.27

160

1093

(3004716) Salmonella sp identified in Stool by Organism specific culture

271

2053

1.35

5.01

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

608

1.63

4.98

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

154

1060

1.48

4.93

1.8

1.6

0.54

0.44

iu/ml

0.08

162

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

128

851

1.53

4.85

4.3

3.4

46.61

47.35

0.14

121

839

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

108

691

1.58

4.85

1.8

1.7

345.73

385.45

mu/l

0.68

562

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

147

1007

1.48

4.83

1.3

9.93

8.85

u/ml

0.05

156

(3044290) Cell count panel - Cerebral spinal fluid

100

629

1.61

4.82

1.2

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

156

1084

1.46

4.77

1.7

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

546

1.65

4.74

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

351

1.81

4.72

1.1

1.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

2.95

4.71

1.8

2.0

1.77

1.73

ug/l

0.04

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

146

1006

1.47

4.67

1.3

3.45

6.54

u/ml

0.46

104

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

281

2166

1.33

4.64

3.1

2.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

210

1548

1.38

4.63

8.1

7.0

6.77

7.54

mmol/l

1.23

200

1494

(3017446) Testosterone [Moles/volume] in Serum or Plasma

559

1.63

4.58

1.4

1.03

1.61

nmol/l

5.54

485

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

355

1.79

4.56

1.9

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

105

678

1.57

4.55

1.2

1.4

18.62

20.99

e6/l

0.09

502

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

110

721

1.54

4.47

1.3

1.2

230.47

250.89

u/ml

0.42

459

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

106

689

1.56

4.47

1.2

1.5

2964.02

6515.53

e6/l

0.26

545

(3045683) HLA typing for celiac disease panel - Blood or Tissue

250

1.93

4.44

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

286

1.87

4.41

1.1

1.2

1.42

1.36

u/ml

0.03

138

(3012501) Base excess in Blood by calculation

396

1.73

4.41

4.2

2.8

1.90

2.43

mmol/l

1.12

248

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

294

1.85

4.38

1.3

1.2

4.67

63.83

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

128

874

1.48

4.31

1.1

1.92

1.64

u/ml

0.09

429

(21494814) CD8 cells/Lymphocytes in Specimen

107

2.44

4.29

2.0

2.3

31.31

28.13

0.52

107

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

132

2.28

4.28

1.4

1.5

19.50

27.17

u/ml

—

(4198724) Urine methamphetamine measurement

165

2.13

4.24

4.8

3.5

—

(3004616) Nuclear Ab [Presence] in Serum

409

1.70

4.22

1.5

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

114

764

1.51

4.21

4.0

2.8

25.22

25.39

mmol/l

0.23

106

742

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.13

4.20

1.1

2.45

1.89

iu/ml

—

(3037121) Protein [Mass/volume] in Urine

113

758

1.51

4.16

2.6

2.9

275.48

328.03

mg/l

0.31

290

(3006922) Hepatitis E virus Ab [Presence] in Serum

228

1.94

4.15

1.1

—

(3008898) HLA-B27 [Presence]

208

1560

1.36

4.15

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

442

1.67

4.14

1.4

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

103

2.44

4.13

1.9

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

103

2.44

4.13

1.9

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

103

2.44

4.13

1.9

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

103

2.44

4.13

1.9

1.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

110

735

1.51

4.12

1.1

6.29

4.98

u/ml

0.23

329

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

101

664

1.54

4.08

1.1

0.04

0.17

u/ml

1.82

186

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

110

2.37

4.06

4.9

2.4

168.24

164.58

umol/l

0.02

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

103

683

1.53

4.01

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

117

2.32

4.01

2.2

1.7

0.16

0.17

e9/l

0.06

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

117

2.32

4.01

1.3

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

168

1225

1.39

3.99

1.5

1.6

0.25

0.28

mg/l

0.14

493

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

130

2.24

3.99

1.3

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

597

1.56

3.95

1.7

1.5

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

247

1918

1.31

3.90

2.7

2.5

69.58

76.10

ml/min/173m2

1.50

106

794

(3017181) Myelocytes/Leukocytes in Blood

295

2346

1.28

3.89

5.6

4.6

0.83

0.98

0.42

558

(3011897) Casein IgE Ab [Units/volume] in Serum

2.64

3.89

1.1

1.2

0.32

0.18

u/ml

0.25

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

113

771

1.48

3.85

2.3

1.9

—

(40761536) Microorganisms panel - Urine sediment

314

2521

1.27

3.84

5.7

3.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

506

1.60

3.84

2.7

2.2

128.35

129.93

g/l

0.32

426

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

101

674

1.51

3.83

1.5

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

642

1.53

3.83

1.8

2.1

158.89

273.57

ug/l

1.37

575

(3003888) Timothy IgE Ab [Units/volume] in Serum

130

915

1.44

3.79

1.1

6.89

5.70

u/ml

0.29

501

(3004588) Protein electrophoresis panel - Serum or Plasma

162

1186

1.39

3.78

2.2

2.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

105

709

1.50

3.77

1.8

2.3

2.70

2.90

g/l

1.46

663

(3008401) Mugwort IgE Ab [Units/volume] in Serum

125

874

1.45

3.77

1.1

0.60

0.90

u/ml

0.63

371

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

168

1240

1.37

3.73

2.4

2.1

3.11

5.81

ug/l

4.31

142

1091

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.57

3.71

1.6

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.57

3.71

1.6

1.8

—

(3002179) Metamyelocytes/Leukocytes in Blood

281

2236

1.28

3.70

5.5

4.4

0.54

0.68

0.52

528

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.01

3.68

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

225

1.88

3.63

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

246

1929

1.30

3.63

1.3

1.4

226.35

232.97

miu/ml

0.10

104

991

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

149

2.09

3.62

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

336

1.71

3.61

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

172

1.99

3.48

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

140

1020

1.39

3.39

2.8

2.3

4.62

4.99

umol/l

0.19

743

(3027923) C peptide [Moles/volume] in Serum or Plasma

133

2.12

3.39

1.9

2.2

1.11

1.53

nmol/l

1.46

(3033099) Centromere Ab [Titer] in Serum

2.51

3.37

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

460

1.58

3.36

1.3

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

261

1.77

3.34

1.4

1.2

87.71

54.20

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

233

1.81

3.29

1.1

1.2

54.09

65.49

u/l

1.05

214

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.48

3.29

1.7

1.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.65

3.29

2.1

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

176

1.94

3.28

1.5

5.37

5.50

u/l

0.08

153

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

740

1.45

3.27

1.8

2.3

7.30

7.39

g/l

0.24

693

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

740

1.45

3.27

1.8

2.3

3.45

3.67

g/l

1.21

694

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

633

1.48

3.26

1.8

2.3

9.33

10.02

g/l

1.10

582

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

112

792

1.43

3.23

1.3

—

5.64

—

(4035726) Immunohistochemistry procedure

260

2089

1.27

3.20

1.5

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

251

1.76

3.16

1.3

1.6

—

(3042517) Benzodiazepines panel - Urine

2.96

3.13

4.8

2.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

305

1.68

3.11

3.9

4.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

194

1.87

3.10

1.2

1.1

—

(3021440) Promyelocytes/Leukocytes in Blood

278

2260

1.25

3.10

5.8

4.6

0.05

0.12

1.33

468

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

105

740

1.43

3.10

1.8

2.3

4.31

4.30

g/l

0.10

693

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.33

3.07

1.3

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

345

1.63

3.06

1.7

1.2

5.02

6.03

umol/l

1.17

314

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

132

971

1.37

3.05

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

545

1.50

3.03

1.3

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

163

1241

1.33

3.02

1.4

1.3

2.62

3.46

ug/l

2.74

150

1149

(3002173) Hemoglobin [Mass/volume] in Arterial blood

213

1684

1.28

3.00

7.1

7.7

119.73

120.04

g/l

0.09

207

1641

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

168

1.91

2.99

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

168

1.91

2.99

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

168

1.91

2.99

1.7

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

263

1.72

2.99

1.7

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

402

1.58

2.99

1.1

1.2

—

0.40

—

(40768441) Liver Pathology biopsy report

190

1.85

2.96

1.5

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

188

1465

1.30

2.96

1.7

3.62

4.18

mg/l

0.40

134

1041

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.47

2.95

1.1

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

128

2.04

2.91

1.2

1.3

—

300.00

—

(3003181) Sodium [Moles/volume] in Urine

350

1.61

2.90

1.9

1.5

57.36

64.00

mmol/l

0.64

286

(3023410) Appearance of Cerebral spinal fluid

319

1.64

2.90

1.2

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

241

1945

1.26

2.88

3.2

4.0

2.93

36.76

ug/l

1.12

171

1458

(3014133) Dog dander IgE Ab [Units/volume] in Serum

109

785

1.40

2.88

1.2

1.1

4.80

3.96

u/ml

0.18

387

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

651

1.44

2.87

1.7

2.4

0.11

0.56

g/l

2.97

573

(3008757) Leukocyte morphology finding [Identifier] in Blood

178

1.86

2.86

3.0

3.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

313

1.64

2.85

1.2

1.1

17.76

13.58

u/ml

0.30

153

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.34

2.81

3.6

3.3

—

20.45

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

118

866

1.38

2.79

1.2

1.3

27.56

39.65

u/ml

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

419

1.54

2.75

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

158

1218

1.31

2.71

2.3

2.8

102.74

128.26

ng/l

0.66

136

1091

(3016502) Oxygen saturation in Arterial blood

216

1738

1.26

2.66

7.1

7.5

96.82

96.43

0.86

209

1681

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

335

1.59

2.65

1.1

1.2

0.15

0.22

nmol/l

0.58

239

(3019977) pH of Arterial blood

248

2029

1.24

2.65

6.6

7.1

7.43

7.42

1.40

131

1090

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.15

2.64

1.0

0.05

0.11

u/ml

0.31

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

489

1.48

2.62

3.7

24.82

41.48

mg/l

1.48

431

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

155

1.88

2.61

1.1

0.29

g/l

0.13

122

(3006462) Nitrate [Presence] in Urine

134

1.95

2.60

2.6

2.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

199

1.77

2.59

1.7

1.8

3.47

2.07

u/ml

—

(3017354) Segmented neutrophils/Leukocytes in Blood

192

1.78

2.58

3.1

2.8

53.10

54.93

0.25

175

(3042631) Mycobacterium sp identified in Specimen

200

1.76

2.56

2.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

276

1.64

2.55

1.3

1.2

119.36

118.04

pmol/l

0.06

276

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

315

1.60

2.55

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

128

1.96

2.55

1.7

1.4

126.27

148.04

mmol/24h

1.19

128

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

403

1.52

2.54

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

403

1.52

2.54

1.4

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

194

1.76

2.50

1.1

1.2

268.57

137.69

titre

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

129

1.95

2.50

1.7

1.6

123.80

141.13

0.79

122

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

357

1.55

2.48

1.2

—

38.13

—

(3011985) Renin [Units/volume] in Plasma

390

1.52

2.46

1.7

1.5

55.73

51.32

mu/l

0.05

350

(3034860) Kappa light chains.free [Mass/volume] in Serum

488

1.47

2.45

3.7

37.44

46.30

mg/l

0.31

429

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

137

1.91

2.45

1.1

28.73

16.33

u/l

0.98

131

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2566

24949

1.15

2.45

20.3

14.5

13.39

13.36

0.53

2541

24619

(3023419) Bacteria identified in Sputum by Culture

218

1.71

2.44

2.2

3.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.24

2.44

1.2

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

138

1.89

2.41

1.1

87.81

68.98

u/l

0.91

132

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

245

2025

1.23

2.40

6.7

7.1

5.04

5.05

kpa

0.10

239

1947

(3027801) Oxygen [Partial pressure] in Arterial blood

245

2026

1.23

2.39

6.6

7.0

12.78

13.68

kpa

2.13

239

1947

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

625

1.40

2.38

1.6

1.3

140.55

150.11

au/ml

0.29

168

(3006442) Creatine [Moles/volume] in Serum or Plasma

153

1.84

2.38

1.4

62.75

68.96

umol/l

1.63

153

(3007463) Buprenorphine [Presence] in Urine

3.64

2.36

9.6

3.8

—

(3017509) Phencyclidine [Presence] in Urine

2.61

2.35

2.7

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

244

1.65

2.34

1.9

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

461

1.46

2.32

3.5

2.5

0.86

nmol/l

0.00

390

(40768793) Breast Pathology biopsy report

134

1037

1.31

2.29

1.4

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.95

2.28

1.6

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.62

2.27

6.2

2.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.56

2.27

1.2

1.6

1.20

1.19

mmol/l

0.12

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

3.48

2.27

1.0

1.2

5.50

14.89

pmol/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

127

1.90

2.25

1.3

1.5

9.29

5.71

u/l

0.32

106

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

692

1.37

2.25

6.3

3.7

1.50

1.30

mg/l

1.19

648

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

358

1.52

2.25

1.5

1.4

395.21

377.03

pmol/l

0.10

315

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

481

1.44

2.25

2.4

2.7

—

(3008295) Osmolality of Serum or Plasma

255

1.62

2.24

1.7

1.6

284.86

279.06

mosm/kgh2o

1.07

207

(3003329) Lymphocytes/Leukocytes in Synovial fluid

179

1.74

2.22

1.5

1.6

35.60

39.63

0.18

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

135

1.86

2.22

1.1

96.73

95.18

0.18

(3036489) Thrombin time

142

1113

1.29

2.21

2.2

2.0

19.94

20.45

1.10

124

940

(3025159) Blasts/Leukocytes in Blood

277

2341

1.20

2.19

6.2

4.8

0.00

0.25

0.80

452

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

249

1.61

2.18

1.8

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

227

1882

1.22

2.18

4.7

3.1

1.23

mmol/l

0.52

193

1622

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.13

2.18

2.8

2.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

468

1.44

2.17

1.3

1.2

2.00

19.34

u/ml

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

129

1.87

2.16

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

116

888

1.32

2.16

2.5

3.58

3.59

g/l

0.03

108

845

(3000330) Specific gravity of Urine by Test strip

156

1242

1.27

2.16

3.7

2.9

1.02

ratio

0.15

136

1081

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

490

4344

1.15

2.16

1.7

3.20

3.23

ratio

0.08

350

3134

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

285

2419

1.20

2.15

1.5

1.12

1.21

ratio

0.90

164

1498

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

285

2419

1.20

2.15

1.5

0.89

0.95

ratio

2.58

162

1490

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.17

2.14

2.7

3.0

55.51

54.84

ng/l

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.30

2.14

1.9

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.30

2.14

1.9

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

227

1.64

2.14

3.6

4.4

7.30

6.73

mmol/l

0.42

187

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

106

802

1.33

2.14

1.3

3.80

3.07

u/ml

—

(3035933) Granulocytes/Leukocytes in Blood

664

1.37

2.14

3.9

3.1

57.14

58.09

0.29

664

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

281

2384

1.20

2.13

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

284

2412

1.19

2.13

1.5

1.13

1.15

ratio

0.13

161

1482

(3032773) Endomysium IgG Ab [Titer] in Serum

356

1.50

2.09

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.21

2.09

2.3

3.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

565

1.39

2.08

1.4

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

2.91

2.07

1.3

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

134

1053

1.28

2.07

4.5

6.4

24.75

24.38

mmol/l

0.74

129

1000

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.08

2.01

1.8

1.9

—

(3021788) Differential panel - Synovial fluid

393

1.46

2.00

1.6

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

725

1.33

1.98

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

320

1.51

1.98

1.1

2.27

2.60

u/ml

0.05

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

504

4506

1.14

1.97

2.0

—

(3022689) Creatine [Moles/volume] in Urine

2.08

1.96

1.7

1.6

9.11

7.31

mmol/l

0.45

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

305

1.52

1.95

1.1

262.56

202.78

mg/l

1.17

275

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

574

1.37

1.91

1.7

2.3

0.00

0.02

g/l

0.82

527

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

390

1.44

1.88

1.3

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

115

899

1.29

1.87

2.7

2.4

160.80

170.21

0.72

109

855

(4094501) Cardiovascular stress test using bicycle ergometer

568

1.36

1.87

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.09

1.86

1.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.09

1.86

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.09

1.86

1.2

1.0

—

(3003396) Base excess in Arterial blood by calculation

237

2009

1.19

1.85

6.9

7.0

0.75

0.78

mmol/l

0.07

197

1620

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

198

1.62

1.83

1.8

1.5

—

(4211845) Urine protein measurement

152

1.72

1.83

2.6

2.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.06

1.80

2.1

1.4

0.20

0.36

nmol/l

—

(3045142) Bone marrow Pathology biopsy report

215

1.59

1.79

1.3

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.76

1.77

1.1

98.80

96.57

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.03

1.75

3.9

2.6

0.63

0.62

mmol/l

0.24

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.98

1.74

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

133

1.73

1.69

1.2

1.1

7.76

4.05

u/ml

0.30

(3003694) ABO and Rh group [Type] in Blood

1105

10401

1.10

1.69

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

493

1.37

1.68

1.1

1.2

99.84

3928.73

iu/ml

0.92

121

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

425

1.40

1.68

3.9

3.6

1.41

2.28

ratio

1.77

236

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

317

1.46

1.66

1.3

1.1

38.53

34.64

mg/l

0.16

270

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.58

1.66

2.4

3.2

25.13

21.47

mg/l

—

(3052592) Norovirus Ag [Presence] in Stool

2.58

1.66

1.0

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

113

1.77

1.60

1.3

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

182

1.60

2.7

2.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

246

1.51

1.60

1.7

53.65

52.56

0.05

142

(3001019) Free T4 and TSH panel - Serum or Plasma

285

2488

1.16

1.59

1.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.00

1.59

1.0

1.1

3.51

5.42

u/ml

0.59

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.00

1.58

1.0

2.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.70

1.58

1.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

388

1.40

1.58

1.8

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

507

4604

1.12

1.56

1.6

959.63

1006.90

mu/l

0.59

403

3904

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

216

1.53

1.54

1.8

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

545

1.33

1.53

1.8

2.3

0.00

g/l

-0.00

488

(3020874) Milk IgE Ab [Units/volume] in Serum

315

1.43

1.52

1.2

1.1

2.41

2.08

u/ml

0.05

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.34

1.52

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

177

1.59

1.51

1.4

1.7

1.27

4.14

nmol/l

1.22

127

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.83

1.51

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.86

1.50

1.2

1.3

0.14

0.16

umol/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.44

1.47

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

285

1.44

1.45

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.31

1.43

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.79

1.43

1.1

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

103

1.75

1.40

1.2

1.1

126.80

252.57

ng/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

271

1.44

1.39

1.2

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.42

1.39

3.1

2.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

373

1.37

1.38

1.6

1.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

206

1.51

1.37

31.4

20.3

1586.48

1540.35

nmol/l

0.13

198

(3025018) Bordetella pertussis Ab [Titer] in Serum

297

1.42

1.37

1.2

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.80

1.37

1.6

2.1

152.80

142.51

au/ml

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

630

0.73

1.36

1.8

1.6

7.24

7.61

mmol/l

0.63

604

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.94

1.36

1.2

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.94

1.36

1.0

1.1

0.00

0.05

u/ml

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

298

1.41

1.35

1.0

0.15

0.25

u/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

332

1.39

1.35

3.6

3.7

16.33

1161.37

u/ml

0.86

308

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

349

1.38

1.35

2.3

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

120

1.67

1.34

1.3

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

373

3361

1.12

1.33

1.6

1.5

3.24

3.40

mmol/l

2.20

239

2189

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

128

1.64

1.33

1.1

12.00

20.26

u/l

0.86

109

(4027681) Cerebrospinal fluid IgG ratio and IgG index

250

1.45

1.30

1.3

1.2

0.53

0.66

ratio

1.82

154

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.50

1.30

6.2

9.7

6.28

5.73

mmol/l

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

2.50

1.30

1.3

2.7

—

1.40

—

(3028433) Virus identified in Specimen by Culture

1.85

1.29

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

145

1.59

1.29

1.7

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

177

1.53

1.28

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.78

1.28

1.4

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

138

1.60

1.26

1.3

1.4

71.16

281.88

nmol/24h

0.53

138

(3016750) Collection duration of Urine

107

1.69

1.25

2.9

2.5

515.85

505.21

min

0.22

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.23

1.24

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

195

1.49

1.24

1.3

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.77

1.23

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.77

1.23

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

313

1.38

1.22

1.1

3.79

8.18

iu/ml

1.23

(44813793) Dust mix specific IgE antibody measurement

296

1.39

1.22

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.63

1.21

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.63

1.21

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

255

1.42

1.19

1.1

—

(3047181) Lactate [Moles/volume] in Blood

559

1.28

1.19

3.8

5.8

1.36

1.23

mmol/l

0.36

488

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

230

1.44

1.19

1.2

1.1

1.48

1.06

u/l

0.70

(3018333) Ribosomal P Ab [Presence] in Serum

272

1.40

1.19

1.3

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

117

1.63

1.18

1.1

1.2

—

0.19

g/l

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

597

1.26

1.16

2.3

1.9

1.94

1.69

ug/l

0.13

533

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

288

2581

1.13

1.15

1.5

59.96

61.75

ug/l

0.27

231

2171

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

2.50

1.15

1.0

1.1

—

26.80

—

(44790047) Parainfluenza type 1 nucleic acid detection

300

1.37

1.14

1.4

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

142

1.55

1.14

1.0

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.69

1.13

1.8

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.34

1.12

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

167

1.50

1.12

1.2

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

135

1.56

1.11

1.5

1.7

93.32

84.20

ng/l

0.25

135

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

302

1.36

1.10

4.5

2.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

285

1.37

1.10

1.2

24.74

18.85

u/l

0.28

246

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.26

1.10

1.1

1.0

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2545

25026

1.09

1.08

20.6

15.0

332.08

331.55

g/l

2.56

2536

24899

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

120

1.59

1.08

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

120

1.59

1.08

1.1

1.0

710.14

799.54

ng/l

0.34

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.76

1.06

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

186

1.46

1.06

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.12

1.05

1.1

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

137

1.54

1.05

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

121

1.57

1.05

1.1

1.0

26.47

47.46

ng/l

2.53

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

1.04

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

237

1.40

1.04

1.2

1.3

1085.71

1067.50

titre

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

162

1.49

1.04

1.7

1.9

1.44

2.21

u/field

0.71

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

280

1.36

1.03

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

154

1.50

1.03

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.06

1.03

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

281

1.36

1.02

1.3

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.88

1.00

1.2

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.00

1.00

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

343

1.32

0.99

1.3

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

189

1.43

0.99

1.1

—

(44790048) Parainfluenza type 2 nucleic acid detection

300

1.34

0.99

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

300

1.34

0.99

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

300

1.34

0.99

1.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.18

0.98

1.0

1.2

—

20.00

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.95

0.97

2.3

3.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.63

0.97

1.9

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.74

0.96

1.9

3.8

1.25

1.31

0.05

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

337

1.31

0.95

1.5

1.6

—

(3004451) EKG impression Narrative

1.69

0.95

1.4

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

130

1503

0.86

0.95

1.1

1.59

1.60

g/l

0.14

130

1503

(40768446) Kidney Pathology biopsy report

1.65

0.94

1.9

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

480

1.25

0.93

1.8

1.7

4968.49

9780.37

e6/l

1.52

338

(3005082) Progesterone [Moles/volume] in Serum or Plasma

507

1.25

0.93

1.5

30.81

38.65

nmol/l

1.15

459

(4015189) Microbial culture of sputum

2.22

0.93

1.2

3.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.82

0.92

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

201

1.40

0.91

2.6

2.8

16.29

14.25

index

0.32

122

(1761482) Bacteria [#/volume] in Urine by Culture

439

1.26

0.88

5.1

3.5

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

2.00

0.87

2.0

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2.00

0.87

1.2

1.1

—

0.52

—

(3000034) Microalbumin [Mass/volume] in Urine

161

1.43

0.86

3.0

29.43

37.96

mg/l

0.15

110

(4195642) Thrombophilia screening test

513

1.23

0.86

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.82

0.85

4.1

2.1

52.77

42.69

pmol/l

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

120

1.50

0.85

1.8

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.63

0.84

1.2

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

560

1.22

0.84

1.2

2.86

4.05

u/ml

0.70

234

(3005011) Chlamydia sp Ab [Titer] in Serum

1.78

0.84

1.3

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

196

1.38

0.84

24.3

14.9

844.48

7437.77

nmol/l

0.50

190

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

123

1069

1.16

0.83

1.4

1.5

0.62

0.47

nmol/l

0.58

870

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

588

1.21

0.83

1.2

3.11

2.95

u/ml

0.04

211

(3050129) First trimester maternal screen panel - Serum or Plasma

326

3004

1.09

0.83

1.6

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

146

1.44

0.82

2.8

2.5

44.83

46.66

0.24

(40765096) Chromosome analysis panel by Banding

1.69

0.82

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.69

0.82

1.4

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

293

1.30

0.81

1.3

1.1

—

(21494434) Karyotype in Bone marrow

155

1.42

0.81

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

294

1.30

0.79

1.3

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

126

1436

0.87

0.79

1.1

0.61

0.60

ratio

0.03

161

(40757373) Influenza virus identified in Isolate

1.82

0.79

1.2

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

1.82

0.79

2.0

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

0.00

0.78

0.0

1.3

—

23.74

—

(3004775) Volume in Urine collected for unspecified duration

131

1.45

0.78

2.9

2.5

803.46

603.32

2.49

100

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.56

0.78

2.4

1.7

9.34

8.65

ug/l

0.29

(40759836) Histone Ab [Presence] in Serum by Immunoblot

296

1.29

0.76

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

641

1.19

0.76

1.6

1.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.52

0.75

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.08

0.74

1.4

2.5

1.80

0.88

u/field

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

533

1.20

0.73

1.2

1.1

116.59

118.71

0.24

476

(4268621) Lupus anticoagulant assay

397

1.24

0.73

2.2

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.00

0.72

1.0

—

53.80

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.00

0.72

1.4

1.2

—

10.37

—

(3029396) Erythrocyte agglutination [Presence] in Blood

230

1.31

0.69

3.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

302

1.26

0.67

1.3

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.49

0.66

1.9

1.5

18.29

17.25

umol/l

0.49

(3051387) C reactive protein [Mass/volume] in Capillary blood

485

1.20

0.66

3.6

3.4

29.70

21.91

mg/l

0.61

324

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

111

1.44

0.65

1.9

1.5

—

(3002619) Bacteria identified in Specimen by Culture

1.57

0.65

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

0.64

1.0

1.1

—

(4034850) Laboratory test

785

1.15

0.63

10.7

7.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.67

0.61

1.0

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1.46

0.61

1.8

15.71

11.60

u/l

0.83

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.08

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

0.08

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.57

0.60

1.3

1.2

—

(3017704) Immunofixation for Urine

1.53

0.59

1.1

1.8

—

(3020650) Glucose [Presence] in Urine

114

1.41

0.58

2.1

1.8

0.00

estimate

-0.00

114

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

123

1.38

0.57

1.9

1.4

—

(3037756) Immunofixation for Serum or Plasma

319

1.23

0.57

2.4

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

285

1.23

0.54

2.3

1.5

—

(4281824) Cell count and differential, peritoneal fluid

341

1.20

0.52

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

1.43

0.52

4.7

4.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.50

0.51

1.0

1.1

0.03

u/ml

—

(3044941) Cell count panel - Synovial fluid

370

1.19

0.50

1.5

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

566

1.15

0.50

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.56

0.49

1.7

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

119

1.35

0.48

1.3

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.46

0.46

1.1

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

227

1.24

0.46

3.4

3.7

0.80

0.78

nmol/l

0.08

185

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

199

0.75

0.46

1.3

1.2

17.47

8.48

mm/h

0.84

199

(3047352) Trisomy 18 risk [Likelihood] in Fetus

213

1990

1.08

0.46

1.5

—

(3014271) Vancomycin [Susceptibility]

1.43

0.46

3.1

2.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

156

1.28

0.45

1.2

1.0

14.19

14.49

u/ml

0.02

116

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

329

1.19

0.45

2.2

4.0

17.78

51.79

u/ml

2.27

329

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

183

1965

0.93

0.44

1.9

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.37

0.43

2.1

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.37

0.43

2.1

1.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

139

1.30

0.43

3.9

4.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

386

1.17

0.43

1.4

1.2

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

157

1.28

0.43

1.1

1.3

—

76.84

—

(3044009) aPTT.lupus sensitive (LA screen)

1.56

0.42

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.52

0.41

1.2

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.13

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.41

0.0

2.6

—

306.73

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.41

0.0

6.6

—

(3001729) Color of Synovial fluid

0.00

0.41

0.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.1

—

8.43

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.40

0.0

1.2

—

3.95

—

(3006598) pH of Arterial cord blood

0.00

0.40

0.0

1.2

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.40

0.0

1.2

—

-1.20

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.00

0.40

0.0

1.1

—

10.78

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.40

0.0

1.2

—

6.93

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.00

0.40

0.0

1.3

—

2206.20

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

172

0.75

0.40

1.2

59.23

70.75

ug/l

0.40

172

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.33

0.40

1.0

1.1

—

(3019174) dRVVT (LA screen)

1.43

0.39

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.41

0.39

1.0

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.19

—

(3005033) Fetal Nuchal fold Thickness US

208

1957

1.07

0.39

1.5

1.19

1.26

1.35

147

1432

(3023199) Leukocytes [#/volume] in Pleural fluid

147

0.75

0.37

1.5

1.4

242.00

3328.87

e6/l

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.35

0.37

1.0

1.1

—

(40768806) Pleura Pathology biopsy report

114

0.70

0.37

1.1

1.7

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

225

1.20

0.37

2.2

32.07

31.50

0.31

225

(44806420) Estimation of glomerular filtration rate

468

1.13

0.37

3.0

2.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

658

1.11

0.36

2.9

3.4

168.04

368.75

u/ml

0.39

567

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

525

1.13

0.36

1.5

1.4

—

(3024263) Appearance of Synovial fluid

1.33

0.35

1.6

2.0

—

(3045788) Cell count panel - Pleural fluid

125

0.72

0.35

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.34

0.34

1.0

1.1

—

89.41

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.34

0.34

1.0

1.1

—

76.29

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

443

1.13

0.34

4.1

0.30

0.38

iu/ml

1.10

247

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

100

1.30

0.33

4.0

1.1

5.49

5.81

nmol/l

0.15

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

155

0.77

0.33

1.4

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

228

2168

1.06

0.32

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

215

2041

1.06

0.32

1.5

1.6

—

(3017569) Oxygen content in Arterial blood

1.33

0.32

2.8

2.5

14.53

16.54

0.69

(40758292) HTLV I+II Ab panel - Serum

1.27

0.30

1.4

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.23

0.29

2.7

2.6

4.69

4.61

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.23

0.29

2.7

2.6

12.59

11.04

kpa

—

(40768795) Lymph node Pathology biopsy report

261

1.15

0.27

1.2

—

(3024932) HLA-DR beta [Type]

1.25

0.27

1.3

1.1

—

(3024471) HLA-A [Type]

1.23

0.27

1.0

—

(3001556) Androgen free Index in Serum or Plasma

1.21

0.26

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.26

0.26

1.1

1.0

14.49

31.61

iu/ml

1.22

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

121

1140

1.06

0.25

1.8

2.2

3.03

8.48

iu/l

0.64

516

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.27

0.24

2.0

2.5

20.45

16.35

umol/l

0.44

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

135

1282

1.06

0.23

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

181

1.16

0.22

1.5

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.22

0.22

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

2.31

—

(3044927) Protein electrophoresis panel - Urine

135

1.19

0.21

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

238.00

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

319.14

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

1.22

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.21

0.0

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

393

1.10

0.20

3.8

4.7

236.07

93.71

u/ml

0.51

133

(3035611) Eosinophils/Leukocytes in Synovial fluid

0.00

0.20

0.0

1.1

—

0.07

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.20

0.0

1.1

—

38.97

—

(3020876) Protein [Mass/time] in 24 hour Urine

222

1.13

0.19

3.2

2.5

1.14

1.03

g/24h

0.11

133

(3041806) Other cells [#/volume] in Blood by Manual count

237

0.89

0.17

1.5

0.54

0.49

e9/l

0.35

237

(4133840) Spirometry

1.11

0.17

1.0

1.2

—

(44806071) Cardiolipin IgM antibody measurement

0.76

0.17

1.0

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

148

1.15

0.17

1.8

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.20

0.16

1.5

2.0

9.33

8.11

mmol/l

0.40

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

254

1.10

0.16

1.1

1.03

1.05

ratio

0.59

205

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

139

0.86

0.14

1.0

1.1

—

5.43

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

627

1.05

0.13

1.5

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

151

1.13

0.13

2.3

2.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.18

0.12

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.18

0.12

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.18

0.12

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.18

0.12

1.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

133

1.13

0.12

1.5

123.27

126.99

nmol/l

0.16

133

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

208

0.91

0.10

6.6

7.5

14.16

14.36

ug/l

0.01

136

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

125

0.88

0.10

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

290

1.07

0.10

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.09

0.09

2.6

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

666

0.96

0.09

1.1

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.09

0.08

2.6

2.1

43.20

41.74

g/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

194

0.93

0.07

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

167

1.08

0.06

1.8

1.4

270539.18

39620.77

e6/l

0.40

110

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

138

1.09

0.06

1.2

1.6

165.47

185.99

u/l

1.46

138

(3012441) Differential panel - Pleural fluid

121

0.91

0.06

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

121

0.91

0.06

1.5

1.4

1593.20

143925.29

e6/l

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

169

1706

0.99

0.03

1.6

1.5

59.93

60.06

ug/l

0.01

169

1706

(3034426) Prothrombin time (PT)

102

1.08

0.03

1.0

1.2

28.73

28.35

0.08

102

(3000012) Reticulocyte production index

229

0.96

0.02

2.3

2.1

1.11

0.84

0.79

134

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

258

0.97

0.02

1.2

1.1

1343.76

1469.94

miu/ml

0.23

258

(37208534) Antinuclear antibody arbitrary concentration in serum

113

1.06

0.01

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

173

1.04

0.01

1.0

—

(21494755) Public health laboratory ask at order entry panel

377

3759

1.00

0.01

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.06

0.01

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

156

0.96

0.00

2.1

2.6

26.45

70.19

ug/l

0.45

148

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

169

1.01

0.00

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.02

0.00

1.0

2.3

—

(3047189) Immunofixation for 24 hour Urine

0.90

-0.00

3.1

1.7

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

176.20

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

1.80

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

200

1.00

-0.00

1.1

—

22.09

u/ml

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.01

-0.00

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

4.8

—

107.17

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

4.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.1

—

204.57

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.94

-0.00

1.0

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1694.29

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_VULVOVAGINFINOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_VULVOVAGINFINOTH	1.303 [1.09, 1.56]	0.004
Birth year	0.996 [0.99, 1.0]	0.405

During the follow-up period (1.1.1998 — 31.12.2019), 476 out of 10556 females with N14_VULVOVAGINFINOTH died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_VULVOVAGINFINOTH.

N-year risk	Females	Males
1	0.112%	No data
5	0.75%	No data
10	1.751%	No data
15	3.739%	No data
20	6.78%	No data

Relationships between endpoints

↥

Index endpoint: N14_VULVOVAGINFINOTH – Vulvovaginal ulceration/inflammation in other diseases

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Vulvovaginal ulceration/inflammation in other diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints